<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><generator>NFE/5.0</generator><title>"actavis pharma" - Google News</title><link>https://news.google.com/search?cf=all&amp;hl=en-US&amp;q=actavis+pharma&amp;cf=all&amp;gl=US&amp;ceid=US:en</link><language>en-US</language><webMaster>news-webmaster@google.com</webMaster><copyright>Copyright © 2026 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><lastBuildDate>Sun, 14 Jun 2026 08:48:55 GMT</lastBuildDate><image><title>Google News</title><url>https://lh3.googleusercontent.com/-DR60l-K8vnyi99NZovm9HlXyZwQ85GMDxiwJWzoasZYCUrPuUM_P_4Rb7ei03j-0nRs0c4F=w256</url><link>https://news.google.com/</link><height>256</height><width>256</width></image><description>Google News</description><item><title>‘By Most Measures A Failure’: Ten Years On From Teva-Actavis - Citeline News &amp; Insights</title><link>https://news.google.com/rss/articles/CBMi3wFBVV95cUxPcUlDc3JiYThBa0RBQUlyblBwQjRQRWRXUnhfSXhkd1ZIRGhKZUowSE92WThEYUhnazh0aHFFZmtwZE9GeXFGemNfQTZpbmtmTEVWN2VnQ2F2czdkYzJjQ2Jxa3pWM0hZUFRORUthTEVacW9pbURZY24tWHZ4Z1gxd0FUWDdrVkY0WllMTThGSUFlRW9EMm5JcnRqclBxNEhWai1ySk1LbmNrOUM5N1lvYzBBaTU1SnI0d1FIeHVvWVo1bkFJN1V6Tnc2RktSdmhtSmhyelotR3lKNVQ5WS04?oc=5</link><guid isPermaLink="false">CBMi3wFBVV95cUxPcUlDc3JiYThBa0RBQUlyblBwQjRQRWRXUnhfSXhkd1ZIRGhKZUowSE92WThEYUhnazh0aHFFZmtwZE9GeXFGemNfQTZpbmtmTEVWN2VnQ2F2czdkYzJjQ2Jxa3pWM0hZUFRORUthTEVacW9pbURZY24tWHZ4Z1gxd0FUWDdrVkY0WllMTThGSUFlRW9EMm5JcnRqclBxNEhWai1ySk1LbmNrOUM5N1lvYzBBaTU1SnI0d1FIeHVvWVo1bkFJN1V6Tnc2RktSdmhtSmhyelotR3lKNVQ5WS04</guid><pubDate>Sun, 27 Jul 2025 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxPcUlDc3JiYThBa0RBQUlyblBwQjRQRWRXUnhfSXhkd1ZIRGhKZUowSE92WThEYUhnazh0aHFFZmtwZE9GeXFGemNfQTZpbmtmTEVWN2VnQ2F2czdkYzJjQ2Jxa3pWM0hZUFRORUthTEVacW9pbURZY24tWHZ4Z1gxd0FUWDdrVkY0WllMTThGSUFlRW9EMm5JcnRqclBxNEhWai1ySk1LbmNrOUM5N1lvYzBBaTU1SnI0d1FIeHVvWVo1bkFJN1V6Tnc2RktSdmhtSmhyelotR3lKNVQ5WS04?oc=5" target="_blank"&gt;‘By Most Measures A Failure’: Ten Years On From Teva-Actavis&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Citeline News &amp; Insights&lt;/font&gt;</description><source url="https://insights.citeline.com">Citeline News &amp; Insights</source></item><item><title>Actavis: A Global Leader in Generic Pharmaceuticals - Pharmacy Times</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTFAtYTkyUUFoNk15NEljSFVjZVpyWlBGczltZ1ZIdVp0N01TWGpZZ1ZFeXVJVTVGdmpJbXNyaEQtTWhfUkVGSE5EQVFWdW9IZENmVXhWTjc5SkJCaFNmUVlISFlKNWhOZw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTFAtYTkyUUFoNk15NEljSFVjZVpyWlBGczltZ1ZIdVp0N01TWGpZZ1ZFeXVJVTVGdmpJbXNyaEQtTWhfUkVGSE5EQVFWdW9IZENmVXhWTjc5SkJCaFNmUVlISFlKNWhOZw</guid><pubDate>Mon, 08 Mar 2021 15:26:49 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFAtYTkyUUFoNk15NEljSFVjZVpyWlBGczltZ1ZIdVp0N01TWGpZZ1ZFeXVJVTVGdmpJbXNyaEQtTWhfUkVGSE5EQVFWdW9IZENmVXhWTjc5SkJCaFNmUVlISFlKNWhOZw?oc=5" target="_blank"&gt;Actavis: A Global Leader in Generic Pharmaceuticals&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Pharmacy Times&lt;/font&gt;</description><source url="https://www.pharmacytimes.com">Pharmacy Times</source></item><item><title>Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries - PR Newswire</title><link>https://news.google.com/rss/articles/CBMijgJBVV95cUxOSk9ncXkwc01sbkZyLWt2OFhPMVNFem9mcTVHTUFrbzFrNnROd3B1UVpxS3pkeVJ3TDNHeE5vR3R4NVJKeGtUYUM2RlFWMThOaXdYb3N3MWNnenFHUm1EeWs2R2NZWnpOZm8tNmx0akl5dlNIVk96ZTQ1WGxRY0lSeVpOeEdOaGRLU2xwRE5hbDRudTlXM2RrMDI5VjZWellNWTJlaFp6SjZqM3B6Q2liNmdSTkttVFVIZ0ZCN3owa1Qwd3FNbVU2ZlBGWDNNTklDTnJlbk1FUElzQ1NJem5xWEFVUjJkcUlNMU5OejhBMVIxamxtTXJKd1pOQ3VoN3JINlQ4LUZNNWYwOHN3OWc?oc=5</link><guid isPermaLink="false">CBMijgJBVV95cUxOSk9ncXkwc01sbkZyLWt2OFhPMVNFem9mcTVHTUFrbzFrNnROd3B1UVpxS3pkeVJ3TDNHeE5vR3R4NVJKeGtUYUM2RlFWMThOaXdYb3N3MWNnenFHUm1EeWs2R2NZWnpOZm8tNmx0akl5dlNIVk96ZTQ1WGxRY0lSeVpOeEdOaGRLU2xwRE5hbDRudTlXM2RrMDI5VjZWellNWTJlaFp6SjZqM3B6Q2liNmdSTkttVFVIZ0ZCN3owa1Qwd3FNbVU2ZlBGWDNNTklDTnJlbk1FUElzQ1NJem5xWEFVUjJkcUlNMU5OejhBMVIxamxtTXJKd1pOQ3VoN3JINlQ4LUZNNWYwOHN3OWc</guid><pubDate>Fri, 17 Jan 2014 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMijgJBVV95cUxOSk9ncXkwc01sbkZyLWt2OFhPMVNFem9mcTVHTUFrbzFrNnROd3B1UVpxS3pkeVJ3TDNHeE5vR3R4NVJKeGtUYUM2RlFWMThOaXdYb3N3MWNnenFHUm1EeWs2R2NZWnpOZm8tNmx0akl5dlNIVk96ZTQ1WGxRY0lSeVpOeEdOaGRLU2xwRE5hbDRudTlXM2RrMDI5VjZWellNWTJlaFp6SjZqM3B6Q2liNmdSTkttVFVIZ0ZCN3owa1Qwd3FNbVU2ZlBGWDNNTklDTnJlbk1FUElzQ1NJem5xWEFVUjJkcUlNMU5OejhBMVIxamxtTXJKd1pOQ3VoN3JINlQ4LUZNNWYwOHN3OWc?oc=5" target="_blank"&gt;Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>TONG LEADS LAWSUIT AGAINST GENERIC DRUG MANUFACTURERSIN CONSPIRACY TO FIX PRICES FOR OVER 100 DRUGS - CT.GOV-Connecticut's Official State Website (.gov)</title><link>https://news.google.com/rss/articles/CBMi8gFBVV95cUxONEtoOHdUZjE3R2x4RW05M1pJc1l4cFAwdDRUNnA3OUd4UE5JQk1lQlpuZEtyc25YZTByckZucExKY0owWW5tekxNS2FGUnNoRENiOTZLVjdybzBuQ0xNZEd0VEpPWHZyUFUyQ1pmZDNxZy1tSktZQ1F5cFdFQmF1Nm03TVVuUXpFYklydWt1VWdVeE44NXl6dU5Reko2aExWV0FGUzNuNmxvbkkzNUpNbTBjNmtaeEFTN0pFbDJTRlVmWjhqcmFGN2dKNlZGMlItbm9mcTRRb1hRSkdfa3ZiRHhDSUhfc3N3djhMblVYaEQwZw?oc=5</link><guid isPermaLink="false">CBMi8gFBVV95cUxONEtoOHdUZjE3R2x4RW05M1pJc1l4cFAwdDRUNnA3OUd4UE5JQk1lQlpuZEtyc25YZTByckZucExKY0owWW5tekxNS2FGUnNoRENiOTZLVjdybzBuQ0xNZEd0VEpPWHZyUFUyQ1pmZDNxZy1tSktZQ1F5cFdFQmF1Nm03TVVuUXpFYklydWt1VWdVeE44NXl6dU5Reko2aExWV0FGUzNuNmxvbkkzNUpNbTBjNmtaeEFTN0pFbDJTRlVmWjhqcmFGN2dKNlZGMlItbm9mcTRRb1hRSkdfa3ZiRHhDSUhfc3N3djhMblVYaEQwZw</guid><pubDate>Sun, 12 May 2019 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi8gFBVV95cUxONEtoOHdUZjE3R2x4RW05M1pJc1l4cFAwdDRUNnA3OUd4UE5JQk1lQlpuZEtyc25YZTByckZucExKY0owWW5tekxNS2FGUnNoRENiOTZLVjdybzBuQ0xNZEd0VEpPWHZyUFUyQ1pmZDNxZy1tSktZQ1F5cFdFQmF1Nm03TVVuUXpFYklydWt1VWdVeE44NXl6dU5Reko2aExWV0FGUzNuNmxvbkkzNUpNbTBjNmtaeEFTN0pFbDJTRlVmWjhqcmFGN2dKNlZGMlItbm9mcTRRb1hRSkdfa3ZiRHhDSUhfc3N3djhMblVYaEQwZw?oc=5" target="_blank"&gt;TONG LEADS LAWSUIT AGAINST GENERIC DRUG MANUFACTURERSIN CONSPIRACY TO FIX PRICES FOR OVER 100 DRUGS&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;CT.GOV-Connecticut's Official State Website (.gov)&lt;/font&gt;</description><source url="https://portal.ct.gov">CT.GOV-Connecticut's Official State Website (.gov)</source></item><item><title>Actavis (now Allergan) - Contract Pharma</title><link>https://news.google.com/rss/articles/CBMifEFVX3lxTE9uNjk4elAxSzVsRzJ0OWQ5d3Q4SXlzTUZXMU9jZlJBNkc5LWg3bFFUc0t1ekVWSFI3bVdJLTYxY21RNDFnRHNMd0JzNlpOWmRtN0lrQi1DZXI5TmZRRUtPbDZEXzNxS2JScUxVTHp5a0c3aUZlSUY3QXZqWDU?oc=5</link><guid isPermaLink="false">CBMifEFVX3lxTE9uNjk4elAxSzVsRzJ0OWQ5d3Q4SXlzTUZXMU9jZlJBNkc5LWg3bFFUc0t1ekVWSFI3bVdJLTYxY21RNDFnRHNMd0JzNlpOWmRtN0lrQi1DZXI5TmZRRUtPbDZEXzNxS2JScUxVTHp5a0c3aUZlSUY3QXZqWDU</guid><pubDate>Sun, 22 Dec 2024 03:29:18 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE9uNjk4elAxSzVsRzJ0OWQ5d3Q4SXlzTUZXMU9jZlJBNkc5LWg3bFFUc0t1ekVWSFI3bVdJLTYxY21RNDFnRHNMd0JzNlpOWmRtN0lrQi1DZXI5TmZRRUtPbDZEXzNxS2JScUxVTHp5a0c3aUZlSUY3QXZqWDU?oc=5" target="_blank"&gt;Actavis (now Allergan)&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Contract Pharma&lt;/font&gt;</description><source url="https://www.contractpharma.com">Contract Pharma</source></item><item><title>FDA flags manufacturing shortcomings at Actavis plant - BioPharma Dive</title><link>https://news.google.com/rss/articles/CBMinAFBVV95cUxQOXJGdnhDUkJyTW14RXFuSzBNZWF3TzAySWluNkV5bVhZekNZcXE2ZmhUT2JHRm40ZnNWdGxMYnhwYUJQeTlPV0xqT0I4TzVYTG45RXdOTV9KQjhWWXdadnZVdWFSRHdIYkM4aFEwVklPbkd1NEVSeGd4RVBnRE5tRUxkUDRZTEtZX0pvNkY3ZU9sUTctUzdDODJZWGs?oc=5</link><guid isPermaLink="false">CBMinAFBVV95cUxQOXJGdnhDUkJyTW14RXFuSzBNZWF3TzAySWluNkV5bVhZekNZcXE2ZmhUT2JHRm40ZnNWdGxMYnhwYUJQeTlPV0xqT0I4TzVYTG45RXdOTV9KQjhWWXdadnZVdWFSRHdIYkM4aFEwVklPbkd1NEVSeGd4RVBnRE5tRUxkUDRZTEtZX0pvNkY3ZU9sUTctUzdDODJZWGs</guid><pubDate>Thu, 07 Mar 2019 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQOXJGdnhDUkJyTW14RXFuSzBNZWF3TzAySWluNkV5bVhZekNZcXE2ZmhUT2JHRm40ZnNWdGxMYnhwYUJQeTlPV0xqT0I4TzVYTG45RXdOTV9KQjhWWXdadnZVdWFSRHdIYkM4aFEwVklPbkd1NEVSeGd4RVBnRE5tRUxkUDRZTEtZX0pvNkY3ZU9sUTctUzdDODJZWGs?oc=5" target="_blank"&gt;FDA flags manufacturing shortcomings at Actavis plant&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;BioPharma Dive&lt;/font&gt;</description><source url="https://www.biopharmadive.com">BioPharma Dive</source></item><item><title>Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue - MultiVu</title><link>https://news.google.com/rss/articles/CBMisgFBVV95cUxNSkxYWktmQUEyUE1DdDVtV2RtNDVxVzJ4RXh3UkROREF2YjVXQ1J6bHRKbV9jc0hHRnNaRjdWZ2JPdVdqNU5sNHlGeGRnODk5ZklKeFZEdW1wcm5ZdTRoOVRUTHpaeHhtcVNtQTktZVlqV25jZ2J0Q09POXU1cmIwSXlBcGU4N0JsWUdFbTlKSnhERzE4QzNZUUF3OGFFb0ZlY0ROZ1JtN3pBNzJxMTBUV1Fn?oc=5</link><guid isPermaLink="false">CBMisgFBVV95cUxNSkxYWktmQUEyUE1DdDVtV2RtNDVxVzJ4RXh3UkROREF2YjVXQ1J6bHRKbV9jc0hHRnNaRjdWZ2JPdVdqNU5sNHlGeGRnODk5ZklKeFZEdW1wcm5ZdTRoOVRUTHpaeHhtcVNtQTktZVlqV25jZ2J0Q09POXU1cmIwSXlBcGU4N0JsWUdFbTlKSnhERzE4QzNZUUF3OGFFb0ZlY0ROZ1JtN3pBNzJxMTBUV1Fn</guid><pubDate>Mon, 17 Nov 2014 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNSkxYWktmQUEyUE1DdDVtV2RtNDVxVzJ4RXh3UkROREF2YjVXQ1J6bHRKbV9jc0hHRnNaRjdWZ2JPdVdqNU5sNHlGeGRnODk5ZklKeFZEdW1wcm5ZdTRoOVRUTHpaeHhtcVNtQTktZVlqV25jZ2J0Q09POXU1cmIwSXlBcGU4N0JsWUdFbTlKSnhERzE4QzNZUUF3OGFFb0ZlY0ROZ1JtN3pBNzJxMTBUV1Fn?oc=5" target="_blank"&gt;Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MultiVu&lt;/font&gt;</description><source url="http://www.multivu.com">MultiVu</source></item><item><title>Actavis Receives Approval of Pantoprazole Sodium Delayed-Release Tablets, USP in the U.S. - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMitwFBVV95cUxQNHZXT0ZGUVk5QVl1Y05HUDF5SXhjSURaTnViNXh6blpxTFRhUWsyb3YwaV9TVXRTTFA4YWJQQVoyS3VGdW9DQVh1ckxscGNrLW52RXZ4SGpOemk4dE1mcWxHaV9EaFBRT182R2NoWkZkenc5emZMcjJGT0ZIakJuYWVIQ192YmgtUnh6cHYycUJIRkUxNkR1RUJBdHdPZ3ZtUVNkTFpsbGZab1BPX1lYRzdxaG54UTQ?oc=5</link><guid isPermaLink="false">CBMitwFBVV95cUxQNHZXT0ZGUVk5QVl1Y05HUDF5SXhjSURaTnViNXh6blpxTFRhUWsyb3YwaV9TVXRTTFA4YWJQQVoyS3VGdW9DQVh1ckxscGNrLW52RXZ4SGpOemk4dE1mcWxHaV9EaFBRT182R2NoWkZkenc5emZMcjJGT0ZIakJuYWVIQ192YmgtUnh6cHYycUJIRkUxNkR1RUJBdHdPZ3ZtUVNkTFpsbGZab1BPX1lYRzdxaG54UTQ</guid><pubDate>Tue, 08 Feb 2011 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQNHZXT0ZGUVk5QVl1Y05HUDF5SXhjSURaTnViNXh6blpxTFRhUWsyb3YwaV9TVXRTTFA4YWJQQVoyS3VGdW9DQVh1ckxscGNrLW52RXZ4SGpOemk4dE1mcWxHaV9EaFBRT182R2NoWkZkenc5emZMcjJGT0ZIakJuYWVIQ192YmgtUnh6cHYycUJIRkUxNkR1RUJBdHdPZ3ZtUVNkTFpsbGZab1BPX1lYRzdxaG54UTQ?oc=5" target="_blank"&gt;Actavis Receives Approval of Pantoprazole Sodium Delayed-Release Tablets, USP in the U.S.&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Watson now third largest generics company with Actavis acquisition - Generics and Biosimilars Initiative</title><link>https://news.google.com/rss/articles/CBMiqwFBVV95cUxPQjBwUWE1TmxIc1FncWh0ZnYxMGtXTFlTekZRN3B3Ym1YQktIZEZqeG5iNjNzbGZsWlI1bmM5UTNQaVVORlJvdDBvRmhqdjk5LUpqX3o1NW9pSVgtOHBoUEQyN2ZHUkpzNElmZmI4UXJsd3JBS191RjlURUtackprVVlyeHQ4bEdTQzR6dnNycG9fWFhBNm9OZTA1dDBJYXF5LU9jWVZGUnFhWDg?oc=5</link><guid isPermaLink="false">CBMiqwFBVV95cUxPQjBwUWE1TmxIc1FncWh0ZnYxMGtXTFlTekZRN3B3Ym1YQktIZEZqeG5iNjNzbGZsWlI1bmM5UTNQaVVORlJvdDBvRmhqdjk5LUpqX3o1NW9pSVgtOHBoUEQyN2ZHUkpzNElmZmI4UXJsd3JBS191RjlURUtackprVVlyeHQ4bEdTQzR6dnNycG9fWFhBNm9OZTA1dDBJYXF5LU9jWVZGUnFhWDg</guid><pubDate>Sun, 04 Jul 2021 22:38:43 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPQjBwUWE1TmxIc1FncWh0ZnYxMGtXTFlTekZRN3B3Ym1YQktIZEZqeG5iNjNzbGZsWlI1bmM5UTNQaVVORlJvdDBvRmhqdjk5LUpqX3o1NW9pSVgtOHBoUEQyN2ZHUkpzNElmZmI4UXJsd3JBS191RjlURUtackprVVlyeHQ4bEdTQzR6dnNycG9fWFhBNm9OZTA1dDBJYXF5LU9jWVZGUnFhWDg?oc=5" target="_blank"&gt;Watson now third largest generics company with Actavis acquisition&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Generics and Biosimilars Initiative&lt;/font&gt;</description><source url="https://www.gabionline.net">Generics and Biosimilars Initiative</source></item><item><title>425 - SEC.gov</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxNNjhCSlgxQ3liVlloU1lfTTg5Mlpyc0pvOVhwZGdMdTk4RVphenE0dUVJVWVZcnM5R09zYkdBS0R3QTZqUkFscm1PR2hlMmp0cE9Gck5kMWhLYmRDZTFxWURRNFhVdzlQdy1mTVVEXzBpVW5ZWkt1MF9KUFV4T1ZjblpsaTVjTlU?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxNNjhCSlgxQ3liVlloU1lfTTg5Mlpyc0pvOVhwZGdMdTk4RVphenE0dUVJVWVZcnM5R09zYkdBS0R3QTZqUkFscm1PR2hlMmp0cE9Gck5kMWhLYmRDZTFxWURRNFhVdzlQdy1mTVVEXzBpVW5ZWkt1MF9KUFV4T1ZjblpsaTVjTlU</guid><pubDate>Thu, 23 Jun 2016 04:42:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNNjhCSlgxQ3liVlloU1lfTTg5Mlpyc0pvOVhwZGdMdTk4RVphenE0dUVJVWVZcnM5R09zYkdBS0R3QTZqUkFscm1PR2hlMmp0cE9Gck5kMWhLYmRDZTFxWURRNFhVdzlQdy1mTVVEXzBpVW5ZWkt1MF9KUFV4T1ZjblpsaTVjTlU?oc=5" target="_blank"&gt;425&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;SEC.gov&lt;/font&gt;</description><source url="https://www.sec.gov">SEC.gov</source></item><item><title>Teva Pharmaceuticals has acquired success with Actavis Generics - worldfinance.com</title><link>https://news.google.com/rss/articles/CBMimgFBVV95cUxNT1NXMXlWNkdGaWNFQk9GVGFITjNwOTFHcy1PSnJDcXZidkZzQWstcnJabElNRXlkSnpiX1JlU0hycjVEMDlReHA5TkYxWEZrVkI2c2tVdFk0OW5UZVRiX1NpQVVIYUJ1MzRhSEpfQzJEaFZFNE1IeFcwR1lxVm1UTl9NQWlRaWxiNG5vRlpfdWpoXzlUUlBkN3RR?oc=5</link><guid isPermaLink="false">CBMimgFBVV95cUxNT1NXMXlWNkdGaWNFQk9GVGFITjNwOTFHcy1PSnJDcXZidkZzQWstcnJabElNRXlkSnpiX1JlU0hycjVEMDlReHA5TkYxWEZrVkI2c2tVdFk0OW5UZVRiX1NpQVVIYUJ1MzRhSEpfQzJEaFZFNE1IeFcwR1lxVm1UTl9NQWlRaWxiNG5vRlpfdWpoXzlUUlBkN3RR</guid><pubDate>Sat, 07 Jan 2017 19:12:46 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNT1NXMXlWNkdGaWNFQk9GVGFITjNwOTFHcy1PSnJDcXZidkZzQWstcnJabElNRXlkSnpiX1JlU0hycjVEMDlReHA5TkYxWEZrVkI2c2tVdFk0OW5UZVRiX1NpQVVIYUJ1MzRhSEpfQzJEaFZFNE1IeFcwR1lxVm1UTl9NQWlRaWxiNG5vRlpfdWpoXzlUUlBkN3RR?oc=5" target="_blank"&gt;Teva Pharmaceuticals has acquired success with Actavis Generics&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;worldfinance.com&lt;/font&gt;</description><source url="https://www.worldfinance.com">worldfinance.com</source></item><item><title>Deals of the Year 2014: Actavis Realizes Bigger Pharma Ambitions - Institutional Investor</title><link>https://news.google.com/rss/articles/CBMi2AFBVV95cUxOMEpwcGNaRXE2ZF9sbFgwbWV4clVLR3d5b0l3ZHRwc1JMT2xqZkNUdE0zNkZDVzNKZVVBc1VONDlrSjNWcGpWOWR1eHNycHk0eFVvTG5tM2s4N3YtZWFZYThMQmpBZjR6OXVjdW1WMkgyOWFNS25BNXF4TWRrdDBwLWpyY3lFcUxyeVZ4Tkd3LThoanVUTkJWYzFUT2d5LWNidUlrdWQ5VGQwbVNnaGxGSGJmM3pZdHZDUHR2S0RfeEhuU01oNWdzcFV0ZjhUWFNjdGZsZzJYTGU?oc=5</link><guid isPermaLink="false">CBMi2AFBVV95cUxOMEpwcGNaRXE2ZF9sbFgwbWV4clVLR3d5b0l3ZHRwc1JMT2xqZkNUdE0zNkZDVzNKZVVBc1VONDlrSjNWcGpWOWR1eHNycHk0eFVvTG5tM2s4N3YtZWFZYThMQmpBZjR6OXVjdW1WMkgyOWFNS25BNXF4TWRrdDBwLWpyY3lFcUxyeVZ4Tkd3LThoanVUTkJWYzFUT2d5LWNidUlrdWQ5VGQwbVNnaGxGSGJmM3pZdHZDUHR2S0RfeEhuU01oNWdzcFV0ZjhUWFNjdGZsZzJYTGU</guid><pubDate>Wed, 10 Dec 2014 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxOMEpwcGNaRXE2ZF9sbFgwbWV4clVLR3d5b0l3ZHRwc1JMT2xqZkNUdE0zNkZDVzNKZVVBc1VONDlrSjNWcGpWOWR1eHNycHk0eFVvTG5tM2s4N3YtZWFZYThMQmpBZjR6OXVjdW1WMkgyOWFNS25BNXF4TWRrdDBwLWpyY3lFcUxyeVZ4Tkd3LThoanVUTkJWYzFUT2d5LWNidUlrdWQ5VGQwbVNnaGxGSGJmM3pZdHZDUHR2S0RfeEhuU01oNWdzcFV0ZjhUWFNjdGZsZzJYTGU?oc=5" target="_blank"&gt;Deals of the Year 2014: Actavis Realizes Bigger Pharma Ambitions&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Institutional Investor&lt;/font&gt;</description><source url="https://www.institutionalinvestor.com">Institutional Investor</source></item><item><title>Actavis Officially Changes Name to Allergan - BioSpace</title><link>https://news.google.com/rss/articles/CBMid0FVX3lxTFBNSkszR2pPeUdXMEE4S0Z3Q0lVSEJrT0VvUmFBdFBJRWg4QzRhNDl0d2FJZklfSXhfbWlqRnJhOUNBempsdk5tamlxcXlnTzFQT3ZDMFJQay1WSnowbEpBVDRBMmozZVdzcUU1WVNBMnJjT2tZN0Rr?oc=5</link><guid isPermaLink="false">CBMid0FVX3lxTFBNSkszR2pPeUdXMEE4S0Z3Q0lVSEJrT0VvUmFBdFBJRWg4QzRhNDl0d2FJZklfSXhfbWlqRnJhOUNBempsdk5tamlxcXlnTzFQT3ZDMFJQay1WSnowbEpBVDRBMmozZVdzcUU1WVNBMnJjT2tZN0Rr</guid><pubDate>Mon, 15 Jun 2015 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFBNSkszR2pPeUdXMEE4S0Z3Q0lVSEJrT0VvUmFBdFBJRWg4QzRhNDl0d2FJZklfSXhfbWlqRnJhOUNBempsdk5tamlxcXlnTzFQT3ZDMFJQay1WSnowbEpBVDRBMmozZVdzcUU1WVNBMnJjT2tZN0Rr?oc=5" target="_blank"&gt;Actavis Officially Changes Name to Allergan&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;BioSpace&lt;/font&gt;</description><source url="https://www.biospace.com">BioSpace</source></item><item><title>Actavis to Divest Doryx® to Mayne Pharma - PR Newswire</title><link>https://news.google.com/rss/articles/CBMimwFBVV95cUxNM2tTU29BME1rbWdiWDNiSGd5OGdmYW85cUlyaTZNckVyWlFNdXVvOUZTUWFYSVIzaXpoUDFyekhnLWsxeFlSc0tmLVZqQ2VBRHNDWmpoUHNLNDNRdmc3VDZscmxVWXZJM0RKN0xjSzlUbE1lTFhFWHNSUXFTaHpPOXl6ZnVFcXF6SkVUTS1uemc1Y05EM0pKa3dpbw?oc=5</link><guid isPermaLink="false">CBMimwFBVV95cUxNM2tTU29BME1rbWdiWDNiSGd5OGdmYW85cUlyaTZNckVyWlFNdXVvOUZTUWFYSVIzaXpoUDFyekhnLWsxeFlSc0tmLVZqQ2VBRHNDWmpoUHNLNDNRdmc3VDZscmxVWXZJM0RKN0xjSzlUbE1lTFhFWHNSUXFTaHpPOXl6ZnVFcXF6SkVUTS1uemc1Y05EM0pKa3dpbw</guid><pubDate>Mon, 09 Feb 2015 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNM2tTU29BME1rbWdiWDNiSGd5OGdmYW85cUlyaTZNckVyWlFNdXVvOUZTUWFYSVIzaXpoUDFyekhnLWsxeFlSc0tmLVZqQ2VBRHNDWmpoUHNLNDNRdmc3VDZscmxVWXZJM0RKN0xjSzlUbE1lTFhFWHNSUXFTaHpPOXl6ZnVFcXF6SkVUTS1uemc1Y05EM0pKa3dpbw?oc=5" target="_blank"&gt;Actavis to Divest Doryx® to Mayne Pharma&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Embattled Teva's surprise generics CEO switch shocks analysts, scares investors - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMipwFBVV95cUxPRm1VM0c1RHN5NWc5MG5lbWt1a2lGdkRzMHFDOU5PRmZfelRDMXZhMjU4VDB5cjRFSTBJdG5TdTQyUVB2c0V1Z2RmQkNyVFJpSF9wQlRUalZ2YWVJbWdiNUtiaVE5eDRrNDhFWnNyU0VYd05pMENKSmJRckNrMjJaNGR0U2k0Qkc0VEQxNEZ5YWVwZFR4dUNQT2RxUU51emN2MDBucndWbw?oc=5</link><guid isPermaLink="false">CBMipwFBVV95cUxPRm1VM0c1RHN5NWc5MG5lbWt1a2lGdkRzMHFDOU5PRmZfelRDMXZhMjU4VDB5cjRFSTBJdG5TdTQyUVB2c0V1Z2RmQkNyVFJpSF9wQlRUalZ2YWVJbWdiNUtiaVE5eDRrNDhFWnNyU0VYd05pMENKSmJRckNrMjJaNGR0U2k0Qkc0VEQxNEZ5YWVwZFR4dUNQT2RxUU51emN2MDBucndWbw</guid><pubDate>Tue, 06 Dec 2016 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPRm1VM0c1RHN5NWc5MG5lbWt1a2lGdkRzMHFDOU5PRmZfelRDMXZhMjU4VDB5cjRFSTBJdG5TdTQyUVB2c0V1Z2RmQkNyVFJpSF9wQlRUalZ2YWVJbWdiNUtiaVE5eDRrNDhFWnNyU0VYd05pMENKSmJRckNrMjJaNGR0U2k0Qkc0VEQxNEZ5YWVwZFR4dUNQT2RxUU51emN2MDBucndWbw?oc=5" target="_blank"&gt;Embattled Teva's surprise generics CEO switch shocks analysts, scares investors&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Watson Pharmaceuticals, Inc. is Now Actavis, Inc. - PR Newswire</title><link>https://news.google.com/rss/articles/CBMiowFBVV95cUxQZFZOMTUyaXZwSzlwSm9oWWpQaG5pNkZUNm9GcHViMUpTc2lQNV9WSlNCa253bVVrVVZhOHhJR1Boazk4Ql9WTWxkRGhTYWxqVnJrZE5fVmdYYVcwNWNjSnV2M1hKV2VsaDVHR2RSMDVmUzU5MDRWTV82cmdUQmYxNEdyWTZSeGVaYmdWU1FxVS1LcG1zS3ZjNk4wMTFHcVpiUktN?oc=5</link><guid isPermaLink="false">CBMiowFBVV95cUxQZFZOMTUyaXZwSzlwSm9oWWpQaG5pNkZUNm9GcHViMUpTc2lQNV9WSlNCa253bVVrVVZhOHhJR1Boazk4Ql9WTWxkRGhTYWxqVnJrZE5fVmdYYVcwNWNjSnV2M1hKV2VsaDVHR2RSMDVmUzU5MDRWTV82cmdUQmYxNEdyWTZSeGVaYmdWU1FxVS1LcG1zS3ZjNk4wMTFHcVpiUktN</guid><pubDate>Thu, 24 Jan 2013 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQZFZOMTUyaXZwSzlwSm9oWWpQaG5pNkZUNm9GcHViMUpTc2lQNV9WSlNCa253bVVrVVZhOHhJR1Boazk4Ql9WTWxkRGhTYWxqVnJrZE5fVmdYYVcwNWNjSnV2M1hKV2VsaDVHR2RSMDVmUzU5MDRWTV82cmdUQmYxNEdyWTZSeGVaYmdWU1FxVS1LcG1zS3ZjNk4wMTFHcVpiUktN?oc=5" target="_blank"&gt;Watson Pharmaceuticals, Inc. is Now Actavis, Inc.&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Actavis plc is now Allergan plc - PR Newswire</title><link>https://news.google.com/rss/articles/CBMikAFBVV95cUxNM0xNc21lNWVFaDlHQWRRMUVCblFzNjRDbWZyY1hRLU5UcjRpalFZcDRZc3RkLWRZN2NnMl9MUzdoV1N4N0JxZW1seUMzV09VUERoWnlWbTZ2amJtVDZsbzVmLXlPZ05yUmIwdnlMREJzczQyMGl3TjdnRGZLSTB4R3JrYW5NVll2c2hhdXRyMzk?oc=5</link><guid isPermaLink="false">CBMikAFBVV95cUxNM0xNc21lNWVFaDlHQWRRMUVCblFzNjRDbWZyY1hRLU5UcjRpalFZcDRZc3RkLWRZN2NnMl9MUzdoV1N4N0JxZW1seUMzV09VUERoWnlWbTZ2amJtVDZsbzVmLXlPZ05yUmIwdnlMREJzczQyMGl3TjdnRGZLSTB4R3JrYW5NVll2c2hhdXRyMzk</guid><pubDate>Tue, 17 Oct 2017 16:23:30 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNM0xNc21lNWVFaDlHQWRRMUVCblFzNjRDbWZyY1hRLU5UcjRpalFZcDRZc3RkLWRZN2NnMl9MUzdoV1N4N0JxZW1seUMzV09VUERoWnlWbTZ2amJtVDZsbzVmLXlPZ05yUmIwdnlMREJzczQyMGl3TjdnRGZLSTB4R3JrYW5NVll2c2hhdXRyMzk?oc=5" target="_blank"&gt;Actavis plc is now Allergan plc&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Actavis Confirms Generic Quillivant XR® Patent Challenge - PR Newswire</title><link>https://news.google.com/rss/articles/CBMisAFBVV95cUxNNkkyckt0YzJJS05NWjlRMlE1aFF0ek53ZlJlZDlxaWo5U0FtYV81TTdJaUtzc0N6VWg0eWJQSVppdzZEb1dNd1dQRi1wUUw4SHZwWXMxTDhkNVRzdUMtZ3VrRWdHUENvblRzOWUzLTJRdmc0b1doeEY3VFNXY0lBQThWa1lKZUlDZ3dTSEc4aE9yTWx1MWVISmt5OEY0cFdxWm5xc2JVbzlEY3pVemMycQ?oc=5</link><guid isPermaLink="false">CBMisAFBVV95cUxNNkkyckt0YzJJS05NWjlRMlE1aFF0ek53ZlJlZDlxaWo5U0FtYV81TTdJaUtzc0N6VWg0eWJQSVppdzZEb1dNd1dQRi1wUUw4SHZwWXMxTDhkNVRzdUMtZ3VrRWdHUENvblRzOWUzLTJRdmc0b1doeEY3VFNXY0lBQThWa1lKZUlDZ3dTSEc4aE9yTWx1MWVISmt5OEY0cFdxWm5xc2JVbzlEY3pVemMycQ</guid><pubDate>Thu, 19 Oct 2017 12:04:23 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxNNkkyckt0YzJJS05NWjlRMlE1aFF0ek53ZlJlZDlxaWo5U0FtYV81TTdJaUtzc0N6VWg0eWJQSVppdzZEb1dNd1dQRi1wUUw4SHZwWXMxTDhkNVRzdUMtZ3VrRWdHUENvblRzOWUzLTJRdmc0b1doeEY3VFNXY0lBQThWa1lKZUlDZ3dTSEc4aE9yTWx1MWVISmt5OEY0cFdxWm5xc2JVbzlEY3pVemMycQ?oc=5" target="_blank"&gt;Actavis Confirms Generic Quillivant XR® Patent Challenge&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Actavis Completes Acquisition of Furiex Pharmaceuticals - PR Newswire</title><link>https://news.google.com/rss/articles/CBMisAFBVV95cUxOVXhlRWJudm9rZGZTeWNoMkFnSlAzRUtDSEpfYTBUckVOdFYtODJxemR4RmRxNGtNZXRKUDdJakwwU1pSZkxudGlodmRFT0NrcEJQc2lFbUZ5LUtMRTBoRGw2WEloN280TTRIVTZtbTFhU0Jla21sdElTaE9MZ1FTMkE3ekdJWGpLalR0aHZlZlctRlNSODZfcDVrOEh2Q0prNmxjbm9WcTJSbVFvczQ1ZA?oc=5</link><guid isPermaLink="false">CBMisAFBVV95cUxOVXhlRWJudm9rZGZTeWNoMkFnSlAzRUtDSEpfYTBUckVOdFYtODJxemR4RmRxNGtNZXRKUDdJakwwU1pSZkxudGlodmRFT0NrcEJQc2lFbUZ5LUtMRTBoRGw2WEloN280TTRIVTZtbTFhU0Jla21sdElTaE9MZ1FTMkE3ekdJWGpLalR0aHZlZlctRlNSODZfcDVrOEh2Q0prNmxjbm9WcTJSbVFvczQ1ZA</guid><pubDate>Wed, 02 Jul 2014 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOVXhlRWJudm9rZGZTeWNoMkFnSlAzRUtDSEpfYTBUckVOdFYtODJxemR4RmRxNGtNZXRKUDdJakwwU1pSZkxudGlodmRFT0NrcEJQc2lFbUZ5LUtMRTBoRGw2WEloN280TTRIVTZtbTFhU0Jla21sdElTaE9MZ1FTMkE3ekdJWGpLalR0aHZlZlctRlNSODZfcDVrOEh2Q0prNmxjbm9WcTJSbVFvczQ1ZA?oc=5" target="_blank"&gt;Actavis Completes Acquisition of Furiex Pharmaceuticals&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company - PR Newswire</title><link>https://news.google.com/rss/articles/CBMi-wFBVV95cUxNMXZpOHI2aDBWWmprMkllU3h6cm5iUUlET0RPWHNQRm1nR2hhdTlIVVV4M1B3X2d1bkY1T0hyUlpQUGtsc2JFcEtUekJLbzEwamVqVUViZG1ubUU2U2NpQTJXd1MzLXgwczdfNmlIdlRhTGluRDFxbE1RbjJreXI2ZmRvWi12N1lxdlVPRE84a3dwZU9oY2VRQjJQcG5oRXdPRm5Qb2I4a2lTWU1WeEFuVjdQbTJYenlGRFg1dnRDZUlRX2FoMnN1eWpFWlJGdWRJMFdLSWljUERxUFhZeU5GWDBsMkZfdmFvV3V2UnJCSjhoRlBwalRBRF9Icw?oc=5</link><guid isPermaLink="false">CBMi-wFBVV95cUxNMXZpOHI2aDBWWmprMkllU3h6cm5iUUlET0RPWHNQRm1nR2hhdTlIVVV4M1B3X2d1bkY1T0hyUlpQUGtsc2JFcEtUekJLbzEwamVqVUViZG1ubUU2U2NpQTJXd1MzLXgwczdfNmlIdlRhTGluRDFxbE1RbjJreXI2ZmRvWi12N1lxdlVPRE84a3dwZU9oY2VRQjJQcG5oRXdPRm5Qb2I4a2lTWU1WeEFuVjdQbTJYenlGRFg1dnRDZUlRX2FoMnN1eWpFWlJGdWRJMFdLSWljUERxUFhZeU5GWDBsMkZfdmFvV3V2UnJCSjhoRlBwalRBRF9Icw</guid><pubDate>Mon, 20 May 2013 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxNMXZpOHI2aDBWWmprMkllU3h6cm5iUUlET0RPWHNQRm1nR2hhdTlIVVV4M1B3X2d1bkY1T0hyUlpQUGtsc2JFcEtUekJLbzEwamVqVUViZG1ubUU2U2NpQTJXd1MzLXgwczdfNmlIdlRhTGluRDFxbE1RbjJreXI2ZmRvWi12N1lxdlVPRE84a3dwZU9oY2VRQjJQcG5oRXdPRm5Qb2I4a2lTWU1WeEFuVjdQbTJYenlGRFg1dnRDZUlRX2FoMnN1eWpFWlJGdWRJMFdLSWljUERxUFhZeU5GWDBsMkZfdmFvV3V2UnJCSjhoRlBwalRBRF9Icw?oc=5" target="_blank"&gt;Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Actavis to acquire generics from Akorn - Generics and Biosimilars Initiative</title><link>https://news.google.com/rss/articles/CBMigwFBVV95cUxOcHkwMzVMLUJ3bEdYWG5mdUYxa2xtSUZfMGZiQkRnSXk3Nm1ZaHNUVkY1aGVYLXdtb3NiVThnay1QWDBsalBuWVBucmtSeDhQQVM1TVVIVk93LS1BMjM3VmxnUHllb3ZONGMzWDFkX1dWdUg4bzRqNXJ0eUMzdDdsS2FLNA?oc=5</link><guid isPermaLink="false">CBMigwFBVV95cUxOcHkwMzVMLUJ3bEdYWG5mdUYxa2xtSUZfMGZiQkRnSXk3Nm1ZaHNUVkY1aGVYLXdtb3NiVThnay1QWDBsalBuWVBucmtSeDhQQVM1TVVIVk93LS1BMjM3VmxnUHllb3ZONGMzWDFkX1dWdUg4bzRqNXJ0eUMzdDdsS2FLNA</guid><pubDate>Tue, 29 Jun 2021 15:22:34 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxOcHkwMzVMLUJ3bEdYWG5mdUYxa2xtSUZfMGZiQkRnSXk3Nm1ZaHNUVkY1aGVYLXdtb3NiVThnay1QWDBsalBuWVBucmtSeDhQQVM1TVVIVk93LS1BMjM3VmxnUHllb3ZONGMzWDFkX1dWdUg4bzRqNXJ0eUMzdDdsS2FLNA?oc=5" target="_blank"&gt;Actavis to acquire generics from Akorn&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Generics and Biosimilars Initiative&lt;/font&gt;</description><source url="https://www.gabionline.net">Generics and Biosimilars Initiative</source></item><item><title>Teva sells Actavis’ UK and Ireland generics business to Intas - Generics and Biosimilars Initiative</title><link>https://news.google.com/rss/articles/CBMingFBVV95cUxQMEZybzJsYnBYVF9KN0UzR2tmVU9oMGFzaU4xU3doS3Bra0RUOTBQWFRubERyb2thZmY1ZlZOT2JILXdwQkFkRzdHemNvNFViVWlxZm9fU2UtaGdQOHhNVHpHRXRxb1hrQWs4RUNPTklBc25tZnFPU3pYcndKMkJCcTJVZGswQ3BYNWlEeEo1VjlhRXVuOF90VkxhYW5pZw?oc=5</link><guid isPermaLink="false">CBMingFBVV95cUxQMEZybzJsYnBYVF9KN0UzR2tmVU9oMGFzaU4xU3doS3Bra0RUOTBQWFRubERyb2thZmY1ZlZOT2JILXdwQkFkRzdHemNvNFViVWlxZm9fU2UtaGdQOHhNVHpHRXRxb1hrQWs4RUNPTklBc25tZnFPU3pYcndKMkJCcTJVZGswQ3BYNWlEeEo1VjlhRXVuOF90VkxhYW5pZw</guid><pubDate>Sun, 08 May 2022 00:12:08 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQMEZybzJsYnBYVF9KN0UzR2tmVU9oMGFzaU4xU3doS3Bra0RUOTBQWFRubERyb2thZmY1ZlZOT2JILXdwQkFkRzdHemNvNFViVWlxZm9fU2UtaGdQOHhNVHpHRXRxb1hrQWs4RUNPTklBc25tZnFPU3pYcndKMkJCcTJVZGswQ3BYNWlEeEo1VjlhRXVuOF90VkxhYW5pZw?oc=5" target="_blank"&gt;Teva sells Actavis’ UK and Ireland generics business to Intas&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Generics and Biosimilars Initiative&lt;/font&gt;</description><source url="https://gabionline.net">Generics and Biosimilars Initiative</source></item><item><title>Teva starts post-Actavis cost squeeze, will eliminate 210 jobs in Malta - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMijwFBVV95cUxQMjBGZGgyMmxhUGhGdnFhVm5SUWpvaWRjbm5zUEpNblZMVjFrUlQ2RjFHTFdsUnhPLUNvankyb20tRjZ4ZlFla3llWGs2OXJ2OUJEQWZHXzNkUTctS0RiaTBLQ2c0ck0tX1E2OWdTY1VwclBDTDJDTG1lS0t0ZmVHREhoMmZMMGY0elJ4ZEFqaw?oc=5</link><guid isPermaLink="false">CBMijwFBVV95cUxQMjBGZGgyMmxhUGhGdnFhVm5SUWpvaWRjbm5zUEpNblZMVjFrUlQ2RjFHTFdsUnhPLUNvankyb20tRjZ4ZlFla3llWGs2OXJ2OUJEQWZHXzNkUTctS0RiaTBLQ2c0ck0tX1E2OWdTY1VwclBDTDJDTG1lS0t0ZmVHREhoMmZMMGY0elJ4ZEFqaw</guid><pubDate>Mon, 28 Nov 2016 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxQMjBGZGgyMmxhUGhGdnFhVm5SUWpvaWRjbm5zUEpNblZMVjFrUlQ2RjFHTFdsUnhPLUNvankyb20tRjZ4ZlFla3llWGs2OXJ2OUJEQWZHXzNkUTctS0RiaTBLQ2c0ck0tX1E2OWdTY1VwclBDTDJDTG1lS0t0ZmVHREhoMmZMMGY0elJ4ZEFqaw?oc=5" target="_blank"&gt;Teva starts post-Actavis cost squeeze, will eliminate 210 jobs in Malta&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Actavis receives generic opioid approval and plans name change - Generics and Biosimilars Initiative</title><link>https://news.google.com/rss/articles/CBMipgFBVV95cUxPYXQ2dUVWcE4za3lxXzVoelBBR0taWXFGSXl0NTZQcUJqVTdoeUlTSEpKd1ZBUkwyRUhRbVFqUngzdjNocVJaNlA0Q21fei1yeW5xSnNJM1YzR203SmVXblZHWHliTi1xd1VVVHVrTFk3TFJYaXkxUUpYTGxsMkNmNUI5V1l4c2JoTlZRblRYb0NIWmlQRV9hYm15VW9rMUhPQnoyRUNB?oc=5</link><guid isPermaLink="false">CBMipgFBVV95cUxPYXQ2dUVWcE4za3lxXzVoelBBR0taWXFGSXl0NTZQcUJqVTdoeUlTSEpKd1ZBUkwyRUhRbVFqUngzdjNocVJaNlA0Q21fei1yeW5xSnNJM1YzR203SmVXblZHWHliTi1xd1VVVHVrTFk3TFJYaXkxUUpYTGxsMkNmNUI5V1l4c2JoTlZRblRYb0NIWmlQRV9hYm15VW9rMUhPQnoyRUNB</guid><pubDate>Tue, 29 Jun 2021 14:25:54 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPYXQ2dUVWcE4za3lxXzVoelBBR0taWXFGSXl0NTZQcUJqVTdoeUlTSEpKd1ZBUkwyRUhRbVFqUngzdjNocVJaNlA0Q21fei1yeW5xSnNJM1YzR203SmVXblZHWHliTi1xd1VVVHVrTFk3TFJYaXkxUUpYTGxsMkNmNUI5V1l4c2JoTlZRblRYb0NIWmlQRV9hYm15VW9rMUhPQnoyRUNB?oc=5" target="_blank"&gt;Actavis receives generic opioid approval and plans name change&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Generics and Biosimilars Initiative&lt;/font&gt;</description><source url="https://www.gabionline.net">Generics and Biosimilars Initiative</source></item><item><title>Actavis pulls Patheon-made pills - BioPharma Dive</title><link>https://news.google.com/rss/articles/CBMigAFBVV95cUxPbThiY2Jpeld1NmlUc29EODd3bnVuUU1TdHpjdm42VUlZMUhhYUhHNElBTndSNlluc2JGdmhmVzFsZzVSZDJGTDFHYzNldkVQLUNDdnhhOXpXMVl3czItSWNFZW1nTUR2dmsxTXhKOWlYRUlvZ29TbHAzbkJ4QlNyWA?oc=5</link><guid isPermaLink="false">CBMigAFBVV95cUxPbThiY2Jpeld1NmlUc29EODd3bnVuUU1TdHpjdm42VUlZMUhhYUhHNElBTndSNlluc2JGdmhmVzFsZzVSZDJGTDFHYzNldkVQLUNDdnhhOXpXMVl3czItSWNFZW1nTUR2dmsxTXhKOWlYRUlvZ29TbHAzbkJ4QlNyWA</guid><pubDate>Thu, 25 Aug 2016 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPbThiY2Jpeld1NmlUc29EODd3bnVuUU1TdHpjdm42VUlZMUhhYUhHNElBTndSNlluc2JGdmhmVzFsZzVSZDJGTDFHYzNldkVQLUNDdnhhOXpXMVl3czItSWNFZW1nTUR2dmsxTXhKOWlYRUlvZ29TbHAzbkJ4QlNyWA?oc=5" target="_blank"&gt;Actavis pulls Patheon-made pills&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;BioPharma Dive&lt;/font&gt;</description><source url="https://www.biopharmadive.com">BioPharma Dive</source></item><item><title>Teva's Actavis again loses bid to invalidate Quillivant ADHD drug patents - Reuters</title><link>https://news.google.com/rss/articles/CBMivwFBVV95cUxQYlJiVWpydklpVXNvY2M0RXNmazVQMnR5V255dzg2NkdGTjBKc0VoMUlzR19mbWhxZ3lMYjFiWVhfV0dMRHVZYUM4bDlveTlVZVBGdUhyV2xhRFhQWUk2cG5pVEY1WTZrVVoyVkdSVmNKSmdhRzdNNXc5SFFrOXNseTdNRkdYNXlWc1IxQW9CcWZYeFZBWG5aQndKQmxFMHRNYkpheFJxa0w0NDV6U3QtTGFJSzRlV2VhSDE1cGhnMA?oc=5</link><guid isPermaLink="false">CBMivwFBVV95cUxQYlJiVWpydklpVXNvY2M0RXNmazVQMnR5V255dzg2NkdGTjBKc0VoMUlzR19mbWhxZ3lMYjFiWVhfV0dMRHVZYUM4bDlveTlVZVBGdUhyV2xhRFhQWUk2cG5pVEY1WTZrVVoyVkdSVmNKSmdhRzdNNXc5SFFrOXNseTdNRkdYNXlWc1IxQW9CcWZYeFZBWG5aQndKQmxFMHRNYkpheFJxa0w0NDV6U3QtTGFJSzRlV2VhSDE1cGhnMA</guid><pubDate>Thu, 07 Jul 2022 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQYlJiVWpydklpVXNvY2M0RXNmazVQMnR5V255dzg2NkdGTjBKc0VoMUlzR19mbWhxZ3lMYjFiWVhfV0dMRHVZYUM4bDlveTlVZVBGdUhyV2xhRFhQWUk2cG5pVEY1WTZrVVoyVkdSVmNKSmdhRzdNNXc5SFFrOXNseTdNRkdYNXlWc1IxQW9CcWZYeFZBWG5aQndKQmxFMHRNYkpheFJxa0w0NDV6U3QtTGFJSzRlV2VhSDE1cGhnMA?oc=5" target="_blank"&gt;Teva's Actavis again loses bid to invalidate Quillivant ADHD drug patents&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Reuters&lt;/font&gt;</description><source url="https://www.reuters.com">Reuters</source></item><item><title>Why you should be paying attention to the lawsuit against Actavis - CNBC</title><link>https://news.google.com/rss/articles/CBMiqAFBVV95cUxPUFllTW5Fc2ZDdkp5b2EtTHdFVXpMcV9RUm9vd2tYWWVEd0VLTWs3VmtKd2Vja3VEZDkxODY4ZEdEc3dKbDBxNXNIYzhQNGZiR0Jsd05zRTNqNFJVU1htNUpCTm1rbi1zeVpvb2ZpWGRYZmxwRzJOTHF2QXVnS2JkOXRORjZWcU5ZbHk2NDgxV2dEQ3VDSkNYMWhNYnlLbjBMd0dmeFJxc2fSAa4BQVVfeXFMTzd6NHNNN0dpS2VLd2FHal9mQ3dnVEJyTzJzY0pYZDVTaUkwQ3F1bC1va1hxR1FjNml1b0tnODZxVDFkUGg2QVFyVmszaWtkaVpDUkpTMkNhRmEzOWdfN0VVaEs5NlBRalZXYlBPWlJxdFhCN2RLMW1ndjlfd0NRYng2ajdGRWtvZzQyOHRPNTVmb0p1dXZuaFVtc241OFZLUXFRelFLRmxlN0Nqd1l3?oc=5</link><guid isPermaLink="false">CBMiqAFBVV95cUxPUFllTW5Fc2ZDdkp5b2EtTHdFVXpMcV9RUm9vd2tYWWVEd0VLTWs3VmtKd2Vja3VEZDkxODY4ZEdEc3dKbDBxNXNIYzhQNGZiR0Jsd05zRTNqNFJVU1htNUpCTm1rbi1zeVpvb2ZpWGRYZmxwRzJOTHF2QXVnS2JkOXRORjZWcU5ZbHk2NDgxV2dEQ3VDSkNYMWhNYnlLbjBMd0dmeFJxc2fSAa4BQVVfeXFMTzd6NHNNN0dpS2VLd2FHal9mQ3dnVEJyTzJzY0pYZDVTaUkwQ3F1bC1va1hxR1FjNml1b0tnODZxVDFkUGg2QVFyVmszaWtkaVpDUkpTMkNhRmEzOWdfN0VVaEs5NlBRalZXYlBPWlJxdFhCN2RLMW1ndjlfd0NRYng2ajdGRWtvZzQyOHRPNTVmb0p1dXZuaFVtc241OFZLUXFRelFLRmxlN0Nqd1l3</guid><pubDate>Wed, 17 Sep 2014 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPUFllTW5Fc2ZDdkp5b2EtTHdFVXpMcV9RUm9vd2tYWWVEd0VLTWs3VmtKd2Vja3VEZDkxODY4ZEdEc3dKbDBxNXNIYzhQNGZiR0Jsd05zRTNqNFJVU1htNUpCTm1rbi1zeVpvb2ZpWGRYZmxwRzJOTHF2QXVnS2JkOXRORjZWcU5ZbHk2NDgxV2dEQ3VDSkNYMWhNYnlLbjBMd0dmeFJxc2fSAa4BQVVfeXFMTzd6NHNNN0dpS2VLd2FHal9mQ3dnVEJyTzJzY0pYZDVTaUkwQ3F1bC1va1hxR1FjNml1b0tnODZxVDFkUGg2QVFyVmszaWtkaVpDUkpTMkNhRmEzOWdfN0VVaEs5NlBRalZXYlBPWlJxdFhCN2RLMW1ndjlfd0NRYng2ajdGRWtvZzQyOHRPNTVmb0p1dXZuaFVtc241OFZLUXFRelFLRmxlN0Nqd1l3?oc=5" target="_blank"&gt;Why you should be paying attention to the lawsuit against Actavis&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;CNBC&lt;/font&gt;</description><source url="https://www.cnbc.com">CNBC</source></item><item><title>Actavis ‘considering’ white knight bid for Allergan - PMLiVE</title><link>https://news.google.com/rss/articles/CBMilgFBVV95cUxNNFFHazBTR1FnZDNfdlhBbkJOS2VZd0liY3J6WlBMcGdvRFpxUFF1NUR6aHBrQnczb3NkMUZfREp0UGxGMGFRNm5ZcFdzNWFXTGZ2Qmg0aXJZS09zZU9WZ0hYNk1CRmdfdVA3aXRoVUZra3hFeEZPWU1id2hscFBfcFpQT2F4aWMxUmk2ZzlFT3U5bFVobVE?oc=5</link><guid isPermaLink="false">CBMilgFBVV95cUxNNFFHazBTR1FnZDNfdlhBbkJOS2VZd0liY3J6WlBMcGdvRFpxUFF1NUR6aHBrQnczb3NkMUZfREp0UGxGMGFRNm5ZcFdzNWFXTGZ2Qmg0aXJZS09zZU9WZ0hYNk1CRmdfdVA3aXRoVUZra3hFeEZPWU1id2hscFBfcFpQT2F4aWMxUmk2ZzlFT3U5bFVobVE</guid><pubDate>Fri, 23 Feb 2024 22:17:38 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNNFFHazBTR1FnZDNfdlhBbkJOS2VZd0liY3J6WlBMcGdvRFpxUFF1NUR6aHBrQnczb3NkMUZfREp0UGxGMGFRNm5ZcFdzNWFXTGZ2Qmg0aXJZS09zZU9WZ0hYNk1CRmdfdVA3aXRoVUZra3hFeEZPWU1id2hscFBfcFpQT2F4aWMxUmk2ZzlFT3U5bFVobVE?oc=5" target="_blank"&gt;Actavis ‘considering’ white knight bid for Allergan&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PMLiVE&lt;/font&gt;</description><source url="https://pmlive.com">PMLiVE</source></item><item><title>Actavis recalls pills made by Patheon - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxQS3B1ODZjMmRQUDBCeFhoamVlQl81TElvSUNoUUJZbUtaSnpoNUJSbHJsVFFIbkJFWVItZWN5ZlNOb0ZfQ0tKLTFFR2FWTzgxa3JEaHk3ZzViRVVlSXZRTlpBdzF0UFUzakNydUFuZWtzT1pzcHFidWJYbTNDUXlPbGFMb0pPeHc?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxQS3B1ODZjMmRQUDBCeFhoamVlQl81TElvSUNoUUJZbUtaSnpoNUJSbHJsVFFIbkJFWVItZWN5ZlNOb0ZfQ0tKLTFFR2FWTzgxa3JEaHk3ZzViRVVlSXZRTlpBdzF0UFUzakNydUFuZWtzT1pzcHFidWJYbTNDUXlPbGFMb0pPeHc</guid><pubDate>Wed, 17 Aug 2016 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQS3B1ODZjMmRQUDBCeFhoamVlQl81TElvSUNoUUJZbUtaSnpoNUJSbHJsVFFIbkJFWVItZWN5ZlNOb0ZfQ0tKLTFFR2FWTzgxa3JEaHk3ZzViRVVlSXZRTlpBdzF0UFUzakNydUFuZWtzT1pzcHFidWJYbTNDUXlPbGFMb0pPeHc?oc=5" target="_blank"&gt;Actavis recalls pills made by Patheon&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Actavis Completes Warner Chilcott Acquisition - PR Newswire</title><link>https://news.google.com/rss/articles/CBMiowFBVV95cUxQQi1RQjhPWWVtNHNEVE4yNTNkOENPcXJYSmRpWTh5SXZHTVBpRk4yZEZPNFRZa3ZBRDNzMGxaTlFWaEM1YVdPbFYwLXl2b2dldHBheGJhbU84S0dkRkdSakktTjFRTTk3NTRpT0hacTVyVFZBb0VJWmVxOFdNMll0dGQteWh4V0dYQXk2ZjhKdko5b2tIRFoxaWsycVYwUHlfOHU4?oc=5</link><guid isPermaLink="false">CBMiowFBVV95cUxQQi1RQjhPWWVtNHNEVE4yNTNkOENPcXJYSmRpWTh5SXZHTVBpRk4yZEZPNFRZa3ZBRDNzMGxaTlFWaEM1YVdPbFYwLXl2b2dldHBheGJhbU84S0dkRkdSakktTjFRTTk3NTRpT0hacTVyVFZBb0VJWmVxOFdNMll0dGQteWh4V0dYQXk2ZjhKdko5b2tIRFoxaWsycVYwUHlfOHU4</guid><pubDate>Tue, 01 Oct 2013 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQQi1RQjhPWWVtNHNEVE4yNTNkOENPcXJYSmRpWTh5SXZHTVBpRk4yZEZPNFRZa3ZBRDNzMGxaTlFWaEM1YVdPbFYwLXl2b2dldHBheGJhbU84S0dkRkdSakktTjFRTTk3NTRpT0hacTVyVFZBb0VJWmVxOFdNMll0dGQteWh4V0dYQXk2ZjhKdko5b2tIRFoxaWsycVYwUHlfOHU4?oc=5" target="_blank"&gt;Actavis Completes Warner Chilcott Acquisition&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMipAFBVV95cUxPdkFNelNMTHFNZFhYUGloYUpPQWdObkpRdnVEV2cwRF9zX2JzWnc5dXlwU1k0bThfOE5xTlYzei1RYVNVQTNEaEJlWHlWTHFEMVBTX2NZU2o3ZGd4eUdQdW1MREJxWVZIQUVya2I0c2pkM3FqTzZRbHpTXzBuN0NNWDEyOTlocmExdmNzU0ZvRy1LaHI3VURhdFB3NjZ4bkRmV1BlaA?oc=5</link><guid isPermaLink="false">CBMipAFBVV95cUxPdkFNelNMTHFNZFhYUGloYUpPQWdObkpRdnVEV2cwRF9zX2JzWnc5dXlwU1k0bThfOE5xTlYzei1RYVNVQTNEaEJlWHlWTHFEMVBTX2NZU2o3ZGd4eUdQdW1MREJxWVZIQUVya2I0c2pkM3FqTzZRbHpTXzBuN0NNWDEyOTlocmExdmNzU0ZvRy1LaHI3VURhdFB3NjZ4bkRmV1BlaA</guid><pubDate>Thu, 14 Apr 2016 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPdkFNelNMTHFNZFhYUGloYUpPQWdObkpRdnVEV2cwRF9zX2JzWnc5dXlwU1k0bThfOE5xTlYzei1RYVNVQTNEaEJlWHlWTHFEMVBTX2NZU2o3ZGd4eUdQdW1MREJxWVZIQUVya2I0c2pkM3FqTzZRbHpTXzBuN0NNWDEyOTlocmExdmNzU0ZvRy1LaHI3VURhdFB3NjZ4bkRmV1BlaA?oc=5" target="_blank"&gt;Allergan’s Actavis recalls nearly 600,000 bottles of ADHD drug&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Actavis to buy Forest for $25 billion; windfall for investor Icahn - Reuters</title><link>https://news.google.com/rss/articles/CBMivAFBVV95cUxOWUprbTRhb3Q2SGRNOElRUThzdEluOVQ1SlhfQ20yWXlUZlc2OVFvdU1VR01DUFk2XzZxN1pHYXJmNzk2WEZpU0RRMVBTY2NGT0dzZFo1aldjellTV0hSaFRMeF80ZjdWanc2TEhQZXRjMmh6cmpqMzBObDAwbGhBa29oTFhsczVvQk8yb01NdGZVQm84OGd3OVlGeDBvbnREQmpGVmVPT3NMSDltVVAwVVZsX2NXUWVqUFpUeQ?oc=5</link><guid isPermaLink="false">CBMivAFBVV95cUxOWUprbTRhb3Q2SGRNOElRUThzdEluOVQ1SlhfQ20yWXlUZlc2OVFvdU1VR01DUFk2XzZxN1pHYXJmNzk2WEZpU0RRMVBTY2NGT0dzZFo1aldjellTV0hSaFRMeF80ZjdWanc2TEhQZXRjMmh6cmpqMzBObDAwbGhBa29oTFhsczVvQk8yb01NdGZVQm84OGd3OVlGeDBvbnREQmpGVmVPT3NMSDltVVAwVVZsX2NXUWVqUFpUeQ</guid><pubDate>Tue, 18 Feb 2014 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOWUprbTRhb3Q2SGRNOElRUThzdEluOVQ1SlhfQ20yWXlUZlc2OVFvdU1VR01DUFk2XzZxN1pHYXJmNzk2WEZpU0RRMVBTY2NGT0dzZFo1aldjellTV0hSaFRMeF80ZjdWanc2TEhQZXRjMmh6cmpqMzBObDAwbGhBa29oTFhsczVvQk8yb01NdGZVQm84OGd3OVlGeDBvbnREQmpGVmVPT3NMSDltVVAwVVZsX2NXUWVqUFpUeQ?oc=5" target="_blank"&gt;Actavis to buy Forest for $25 billion; windfall for investor Icahn&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Reuters&lt;/font&gt;</description><source url="https://www.reuters.com">Reuters</source></item><item><title>Alvotech announces new CEO and chief operating officer - drugdiscoverytrends.com</title><link>https://news.google.com/rss/articles/CBMilgFBVV95cUxQejlsMDloV1lXeERBRWtJcGpraGZiS2xWQlRZUzZFTnBQcmxMa3RoeDBYZHNaMlFaZVZzZGxKTlRLMUplWVB3TnJWYkhETGd6REVyYkNfZUl3UVppYjg0WlZITFZ4cEhxcUN5YWVCOFdMdzV0U0JxcUJIS1Z1SlppM0J3UDM4ajVhVVlWVjFIc0NNR2Q5dXc?oc=5</link><guid isPermaLink="false">CBMilgFBVV95cUxQejlsMDloV1lXeERBRWtJcGpraGZiS2xWQlRZUzZFTnBQcmxMa3RoeDBYZHNaMlFaZVZzZGxKTlRLMUplWVB3TnJWYkhETGd6REVyYkNfZUl3UVppYjg0WlZITFZ4cEhxcUN5YWVCOFdMdzV0U0JxcUJIS1Z1SlppM0J3UDM4ajVhVVlWVjFIc0NNR2Q5dXc</guid><pubDate>Fri, 02 Dec 2022 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQejlsMDloV1lXeERBRWtJcGpraGZiS2xWQlRZUzZFTnBQcmxMa3RoeDBYZHNaMlFaZVZzZGxKTlRLMUplWVB3TnJWYkhETGd6REVyYkNfZUl3UVppYjg0WlZITFZ4cEhxcUN5YWVCOFdMdzV0U0JxcUJIS1Z1SlppM0J3UDM4ajVhVVlWVjFIc0NNR2Q5dXc?oc=5" target="_blank"&gt;Alvotech announces new CEO and chief operating officer&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;drugdiscoverytrends.com&lt;/font&gt;</description><source url="https://www.drugdiscoverytrends.com">drugdiscoverytrends.com</source></item><item><title>Teva cuts 14,000 jobs: The inside story of how Israeli drugmaker wiped out $57 billion in two years - Haaretz</title><link>https://news.google.com/rss/articles/CBMi9gFBVV95cUxPZ3dETjRMVUZVT2VrckdnOG5nSmg5SjNFdXhLT25aZ2dHRmdCV3J2M0NuRzlUbEpZb3ZSTnpxNVZVa09xaVdMbk55bXdKY0JkeElwZXpKQWxFYk13RlRLV1BFMzgyY3Z2a0cxcGRzT3lDVlZqdWJlMjFiQ1UzNmNHQzh2d3pXa2tIWlJmZERlSkJYQzJTcTNQV0N0aWtrbWtrdC02ajhPSTZzQXJtbXFHRk1NcmcxMTV6dVVEQUFTTDNsdkptS3d0RFdPT2t3OS0yTlo2Z3dnejl6QS1YVFE4VkpnaktOeFVtbDRBOXpYMVJDQ003Qnc?oc=5</link><guid isPermaLink="false">CBMi9gFBVV95cUxPZ3dETjRMVUZVT2VrckdnOG5nSmg5SjNFdXhLT25aZ2dHRmdCV3J2M0NuRzlUbEpZb3ZSTnpxNVZVa09xaVdMbk55bXdKY0JkeElwZXpKQWxFYk13RlRLV1BFMzgyY3Z2a0cxcGRzT3lDVlZqdWJlMjFiQ1UzNmNHQzh2d3pXa2tIWlJmZERlSkJYQzJTcTNQV0N0aWtrbWtrdC02ajhPSTZzQXJtbXFHRk1NcmcxMTV6dVVEQUFTTDNsdkptS3d0RFdPT2t3OS0yTlo2Z3dnejl6QS1YVFE4VkpnaktOeFVtbDRBOXpYMVJDQ003Qnc</guid><pubDate>Sun, 17 Dec 2017 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi9gFBVV95cUxPZ3dETjRMVUZVT2VrckdnOG5nSmg5SjNFdXhLT25aZ2dHRmdCV3J2M0NuRzlUbEpZb3ZSTnpxNVZVa09xaVdMbk55bXdKY0JkeElwZXpKQWxFYk13RlRLV1BFMzgyY3Z2a0cxcGRzT3lDVlZqdWJlMjFiQ1UzNmNHQzh2d3pXa2tIWlJmZERlSkJYQzJTcTNQV0N0aWtrbWtrdC02ajhPSTZzQXJtbXFHRk1NcmcxMTV6dVVEQUFTTDNsdkptS3d0RFdPT2t3OS0yTlo2Z3dnejl6QS1YVFE4VkpnaktOeFVtbDRBOXpYMVJDQ003Qnc?oc=5" target="_blank"&gt;Teva cuts 14,000 jobs: The inside story of how Israeli drugmaker wiped out $57 billion in two years&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Haaretz&lt;/font&gt;</description><source url="https://www.haaretz.com">Haaretz</source></item><item><title>From Actavis to Allergan: One pharma company’s wild dealmaking journey - Fortune</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE9iUERqaVRhVEd1Zk1uUFRYTmVNMU9WLW1QcWxzdDJ3SV9GVXhzenUwREhXdHk5dHAyeEt6WEJHdWoybXJRZnY5UktIRHA5OUhnX0dLUzA2VURiV3N3SGgzWXBqNXotT0g1?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE9iUERqaVRhVEd1Zk1uUFRYTmVNMU9WLW1QcWxzdDJ3SV9GVXhzenUwREhXdHk5dHAyeEt6WEJHdWoybXJRZnY5UktIRHA5OUhnX0dLUzA2VURiV3N3SGgzWXBqNXotT0g1</guid><pubDate>Thu, 30 Jul 2015 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE9iUERqaVRhVEd1Zk1uUFRYTmVNMU9WLW1QcWxzdDJ3SV9GVXhzenUwREhXdHk5dHAyeEt6WEJHdWoybXJRZnY5UktIRHA5OUhnX0dLUzA2VURiV3N3SGgzWXBqNXotT0g1?oc=5" target="_blank"&gt;From Actavis to Allergan: One pharma company’s wild dealmaking journey&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fortune&lt;/font&gt;</description><source url="https://fortune.com">Fortune</source></item><item><title>Tribunal upholds £130M fine after UK authorities probed 10,000% price hike - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMiwAFBVV95cUxOWTJJeUdrSjQ5TFM5S1JlZ1ZKa19jVmZ6dTZhYlQxLUVldW00cl96ZUZmOFFOZllsMGdMSlowLWFfMWxRR3ZYSmlYNlN0TFVOQUl6SVNPSXdzc1gzUXBNMDlldWppblVfc1hJMHktUnpVWUkxQlNGM1NxZ3FmN2tWeDlRajlLMVBSbXBGT2FkMlprRFZkS2hzcnhXcjE1RHBobkRiVElmVlIzSVNmY2E3V09OYm5zRkZqQ0Q1ZFBwTi0?oc=5</link><guid isPermaLink="false">CBMiwAFBVV95cUxOWTJJeUdrSjQ5TFM5S1JlZ1ZKa19jVmZ6dTZhYlQxLUVldW00cl96ZUZmOFFOZllsMGdMSlowLWFfMWxRR3ZYSmlYNlN0TFVOQUl6SVNPSXdzc1gzUXBNMDlldWppblVfc1hJMHktUnpVWUkxQlNGM1NxZ3FmN2tWeDlRajlLMVBSbXBGT2FkMlprRFZkS2hzcnhXcjE1RHBobkRiVElmVlIzSVNmY2E3V09OYm5zRkZqQ0Q1ZFBwTi0</guid><pubDate>Tue, 19 Sep 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOWTJJeUdrSjQ5TFM5S1JlZ1ZKa19jVmZ6dTZhYlQxLUVldW00cl96ZUZmOFFOZllsMGdMSlowLWFfMWxRR3ZYSmlYNlN0TFVOQUl6SVNPSXdzc1gzUXBNMDlldWppblVfc1hJMHktUnpVWUkxQlNGM1NxZ3FmN2tWeDlRajlLMVBSbXBGT2FkMlprRFZkS2hzcnhXcjE1RHBobkRiVElmVlIzSVNmY2E3V09OYm5zRkZqQ0Q1ZFBwTi0?oc=5" target="_blank"&gt;Tribunal upholds £130M fine after UK authorities probed 10,000% price hike&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Watson to Acquire Actavis Group for EUR4.25 Billion - PR Newswire</title><link>https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZW5TdGlNSDA0bmVwTHlISHM0TG5pc3ZjZ0FMQ2dFRzRIcU94MzdwNGtFb0tMdDFpdWpFdmVzVmdBRmZUVEFFV2xHaXRNbWczbDRPdEloWnJVRTY4MlBzVnB6UTNxb3dEOXJSR1lhQXhFX0lsaFNmaF9GaXRWT1JhZVZvdm1BRTBqOHJoWjVmNF91Ymw2aXdFQWdaUmlXQmp5NExqaTNlZGNTdw?oc=5</link><guid isPermaLink="false">CBMiqgFBVV95cUxQZW5TdGlNSDA0bmVwTHlISHM0TG5pc3ZjZ0FMQ2dFRzRIcU94MzdwNGtFb0tMdDFpdWpFdmVzVmdBRmZUVEFFV2xHaXRNbWczbDRPdEloWnJVRTY4MlBzVnB6UTNxb3dEOXJSR1lhQXhFX0lsaFNmaF9GaXRWT1JhZVZvdm1BRTBqOHJoWjVmNF91Ymw2aXdFQWdaUmlXQmp5NExqaTNlZGNTdw</guid><pubDate>Wed, 25 Apr 2012 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZW5TdGlNSDA0bmVwTHlISHM0TG5pc3ZjZ0FMQ2dFRzRIcU94MzdwNGtFb0tMdDFpdWpFdmVzVmdBRmZUVEFFV2xHaXRNbWczbDRPdEloWnJVRTY4MlBzVnB6UTNxb3dEOXJSR1lhQXhFX0lsaFNmaF9GaXRWT1JhZVZvdm1BRTBqOHJoWjVmNF91Ymw2aXdFQWdaUmlXQmp5NExqaTNlZGNTdw?oc=5" target="_blank"&gt;Watson to Acquire Actavis Group for EUR4.25 Billion&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Actavis Completes Forest Laboratories Acquisition - PR Newswire</title><link>https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbkpXV20yc0tBT2hEWGotSjlGal9pU2tyc0huaWQxTm1QNjllZTRwbWxDWkxvRlBzNmJXUDRJOE92TWt4ZUFZRlhtQURKV1RVTENYVHpGWlBfYmIxWjl1b0k4SjByaE5yT2tqTzV2RWFiVE9PQzFpY2NxNS14ZVZGYXRJYW5qam16R0piNU8tem56VmFvS003MjlOV0Q4aVE4NDFoY1I1MV8?oc=5</link><guid isPermaLink="false">CBMiqAFBVV95cUxNbkpXV20yc0tBT2hEWGotSjlGal9pU2tyc0huaWQxTm1QNjllZTRwbWxDWkxvRlBzNmJXUDRJOE92TWt4ZUFZRlhtQURKV1RVTENYVHpGWlBfYmIxWjl1b0k4SjByaE5yT2tqTzV2RWFiVE9PQzFpY2NxNS14ZVZGYXRJYW5qam16R0piNU8tem56VmFvS003MjlOV0Q4aVE4NDFoY1I1MV8</guid><pubDate>Mon, 30 Oct 2017 13:43:26 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNbkpXV20yc0tBT2hEWGotSjlGal9pU2tyc0huaWQxTm1QNjllZTRwbWxDWkxvRlBzNmJXUDRJOE92TWt4ZUFZRlhtQURKV1RVTENYVHpGWlBfYmIxWjl1b0k4SjByaE5yT2tqTzV2RWFiVE9PQzFpY2NxNS14ZVZGYXRJYW5qam16R0piNU8tem56VmFvS003MjlOV0Q4aVE4NDFoY1I1MV8?oc=5" target="_blank"&gt;Actavis Completes Forest Laboratories Acquisition&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PR Newswire&lt;/font&gt;</description><source url="https://www.prnewswire.com">PR Newswire</source></item><item><title>Actavis Approved for Generic Subutex - Medical Professionals Reference</title><link>https://news.google.com/rss/articles/CBMiigFBVV95cUxPcFlwNXBJSk9TdGhsXzE5UXNZdjZvWF9paFZHckU3UlNQN2pfSHpGdUhacm1xVjVEaHd5M3ExajBEdHg3bXJ5bzNZbkZYYUlxOGVqUFhFbERsS20xejRidVdQSHNNRUZkallqZW1MUFBrM1J6VDY4RHMzbFV6aV9DOTJKa0s0bE9NR1E?oc=5</link><guid isPermaLink="false">CBMiigFBVV95cUxPcFlwNXBJSk9TdGhsXzE5UXNZdjZvWF9paFZHckU3UlNQN2pfSHpGdUhacm1xVjVEaHd5M3ExajBEdHg3bXJ5bzNZbkZYYUlxOGVqUFhFbERsS20xejRidVdQSHNNRUZkallqZW1MUFBrM1J6VDY4RHMzbFV6aV9DOTJKa0s0bE9NR1E</guid><pubDate>Fri, 20 Feb 2015 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxPcFlwNXBJSk9TdGhsXzE5UXNZdjZvWF9paFZHckU3UlNQN2pfSHpGdUhacm1xVjVEaHd5M3ExajBEdHg3bXJ5bzNZbkZYYUlxOGVqUFhFbERsS20xejRidVdQSHNNRUZkallqZW1MUFBrM1J6VDY4RHMzbFV6aV9DOTJKa0s0bE9NR1E?oc=5" target="_blank"&gt;Actavis Approved for Generic Subutex&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Medical Professionals Reference&lt;/font&gt;</description><source url="https://www.empr.com">Medical Professionals Reference</source></item><item><title>Actavis makes Aurobindo sale - Pharmafile</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE9lMU1zSjEyZUpyZHRuaS1wUmdqdUpTWnFhVk1BUkRkaWwyX3FiOUxJZDdPcmIwcElxNzNlOWtjT1VZaHRuY3NyeFluTk1RbTBMd1ZfT2lmbkVrZUFRM09VZ1V4dTM0Q2VL?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE9lMU1zSjEyZUpyZHRuaS1wUmdqdUpTWnFhVk1BUkRkaWwyX3FiOUxJZDdPcmIwcElxNzNlOWtjT1VZaHRuY3NyeFluTk1RbTBMd1ZfT2lmbkVrZUFRM09VZ1V4dTM0Q2VL</guid><pubDate>Tue, 21 Jan 2014 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE9lMU1zSjEyZUpyZHRuaS1wUmdqdUpTWnFhVk1BUkRkaWwyX3FiOUxJZDdPcmIwcElxNzNlOWtjT1VZaHRuY3NyeFluTk1RbTBMd1ZfT2lmbkVrZUFRM09VZ1V4dTM0Q2VL?oc=5" target="_blank"&gt;Actavis makes Aurobindo sale&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Pharmafile&lt;/font&gt;</description><source url="https://pharmafile.com">Pharmafile</source></item><item><title>Bisaro, Amneal poach top Allergan exec for CEO's chair - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMitwFBVV95cUxObUpYS1ZoNlJiVHpFMWw1aW5lT0hCMzViSkRiQ0lDT2xzRnZQMjBEMHZaZFUxTXIzV05LQm1Pa1AyMnFzSlJKVjZzbDN5RDRSd1NPYkxkazF0bFFULV9XNllDMFUxM0VWQVlGRk8yamFTMEF4VmgwMlF5emdxZTd6UnhVZ2dLSUQ3R2ZCTzlSeW1DNFg3bElMdU9xWUJIaHlsNjNnTW9hR2V6azBCTXFvYUc0NEhMNm8?oc=5</link><guid isPermaLink="false">CBMitwFBVV95cUxObUpYS1ZoNlJiVHpFMWw1aW5lT0hCMzViSkRiQ0lDT2xzRnZQMjBEMHZaZFUxTXIzV05LQm1Pa1AyMnFzSlJKVjZzbDN5RDRSd1NPYkxkazF0bFFULV9XNllDMFUxM0VWQVlGRk8yamFTMEF4VmgwMlF5emdxZTd6UnhVZ2dLSUQ3R2ZCTzlSeW1DNFg3bElMdU9xWUJIaHlsNjNnTW9hR2V6azBCTXFvYUc0NEhMNm8</guid><pubDate>Mon, 18 Dec 2017 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxObUpYS1ZoNlJiVHpFMWw1aW5lT0hCMzViSkRiQ0lDT2xzRnZQMjBEMHZaZFUxTXIzV05LQm1Pa1AyMnFzSlJKVjZzbDN5RDRSd1NPYkxkazF0bFFULV9XNllDMFUxM0VWQVlGRk8yamFTMEF4VmgwMlF5emdxZTd6UnhVZ2dLSUQ3R2ZCTzlSeW1DNFg3bElMdU9xWUJIaHlsNjNnTW9hR2V6azBCTXFvYUc0NEhMNm8?oc=5" target="_blank"&gt;Bisaro, Amneal poach top Allergan exec for CEO's chair&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Drugs firms face fresh questions after Actavis accused of 12,000% price hike | Pharmaceuticals industry - The Guardian</title><link>https://news.google.com/rss/articles/CBMiuAFBVV95cUxOeFN0NENYVktVSExoQTFKZEVSU2lTczFWOWpwMGhXeEtvYS1KNXVLdWx3VGlBNHI5RGl4UXFfaXdDckRiWFMtNmZlMWk0aVdqSWRNQU5GTmwwZW5WaC05TEdiM01lcWg1LUYtQnBmV0MtSk5GWkwtbmR1U09YYTVJQy1sODR4SWNUeFRnaWFLMC1lXzJtZ2FQQUR2cXNwQUs1WTZ4STl0UVJ1NUVaREhaY1JkN1Jmdllk?oc=5</link><guid isPermaLink="false">CBMiuAFBVV95cUxOeFN0NENYVktVSExoQTFKZEVSU2lTczFWOWpwMGhXeEtvYS1KNXVLdWx3VGlBNHI5RGl4UXFfaXdDckRiWFMtNmZlMWk0aVdqSWRNQU5GTmwwZW5WaC05TEdiM01lcWg1LUYtQnBmV0MtSk5GWkwtbmR1U09YYTVJQy1sODR4SWNUeFRnaWFLMC1lXzJtZ2FQQUR2cXNwQUs1WTZ4STl0UVJ1NUVaREhaY1JkN1Jmdllk</guid><pubDate>Fri, 16 Dec 2016 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOeFN0NENYVktVSExoQTFKZEVSU2lTczFWOWpwMGhXeEtvYS1KNXVLdWx3VGlBNHI5RGl4UXFfaXdDckRiWFMtNmZlMWk0aVdqSWRNQU5GTmwwZW5WaC05TEdiM01lcWg1LUYtQnBmV0MtSk5GWkwtbmR1U09YYTVJQy1sODR4SWNUeFRnaWFLMC1lXzJtZ2FQQUR2cXNwQUs1WTZ4STl0UVJ1NUVaREhaY1JkN1Jmdllk?oc=5" target="_blank"&gt;Drugs firms face fresh questions after Actavis accused of 12,000% price hike | Pharmaceuticals industry&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Guardian&lt;/font&gt;</description><source url="https://www.theguardian.com">The Guardian</source></item><item><title>UCB loses its appeal in Neupro patent case, giving Teva and Viatris a win - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMivwFBVV95cUxONzFNQTNhX29jcmxjZlRsLTFVVC1hNUFPbHJGVFhFUWRpbHRyZHhyb3VOYmxDT3o0dGZlcG9JbmZFS0dvcUVmaTJuNnVnRDVhUXQ5VzN0dC1ISnlVN2xJV3NUekNZWURwaXVHVExKTUVzX291YzJ5Y3VYNkdUMUU1ZXVhY2lWS3NNb09nXzJ0ejdqRHd6UzZOWFpMb0tlTDVubnNfUFQxTURTTGpDbXdTTEdCY3BxTHhFU0V1UmZQUQ?oc=5</link><guid isPermaLink="false">CBMivwFBVV95cUxONzFNQTNhX29jcmxjZlRsLTFVVC1hNUFPbHJGVFhFUWRpbHRyZHhyb3VOYmxDT3o0dGZlcG9JbmZFS0dvcUVmaTJuNnVnRDVhUXQ5VzN0dC1ISnlVN2xJV3NUekNZWURwaXVHVExKTUVzX291YzJ5Y3VYNkdUMUU1ZXVhY2lWS3NNb09nXzJ0ejdqRHd6UzZOWFpMb0tlTDVubnNfUFQxTURTTGpDbXdTTEdCY3BxTHhFU0V1UmZQUQ</guid><pubDate>Thu, 13 Apr 2023 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxONzFNQTNhX29jcmxjZlRsLTFVVC1hNUFPbHJGVFhFUWRpbHRyZHhyb3VOYmxDT3o0dGZlcG9JbmZFS0dvcUVmaTJuNnVnRDVhUXQ5VzN0dC1ISnlVN2xJV3NUekNZWURwaXVHVExKTUVzX291YzJ5Y3VYNkdUMUU1ZXVhY2lWS3NNb09nXzJ0ejdqRHd6UzZOWFpMb0tlTDVubnNfUFQxTURTTGpDbXdTTEdCY3BxTHhFU0V1UmZQUQ?oc=5" target="_blank"&gt;UCB loses its appeal in Neupro patent case, giving Teva and Viatris a win&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Botox maker Allergan close to $66bn tie-up with Actavis - The Guardian</title><link>https://news.google.com/rss/articles/CBMiogFBVV95cUxObXpoZUNraGxSUDAxT1hPMjJTV1RWVE1RdFhaTlJ3STI1TU5MTWloRHBUdHFhU2ZnUEJoaWlLZmJlQWZlTk43enE4aXhNLUl2WHZsRlBGU1dnZUFfWFNoU1ZSUWx3QW96UjZsaWlyeE56LUZ3TjZ4R1RqN09MQzE3NmlSS1RBX0RzZW9GOTVoR1VoUGNjS1BUbUVTNzhhNXQyREE?oc=5</link><guid isPermaLink="false">CBMiogFBVV95cUxObXpoZUNraGxSUDAxT1hPMjJTV1RWVE1RdFhaTlJ3STI1TU5MTWloRHBUdHFhU2ZnUEJoaWlLZmJlQWZlTk43enE4aXhNLUl2WHZsRlBGU1dnZUFfWFNoU1ZSUWx3QW96UjZsaWlyeE56LUZ3TjZ4R1RqN09MQzE3NmlSS1RBX0RzZW9GOTVoR1VoUGNjS1BUbUVTNzhhNXQyREE</guid><pubDate>Mon, 17 Nov 2014 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxObXpoZUNraGxSUDAxT1hPMjJTV1RWVE1RdFhaTlJ3STI1TU5MTWloRHBUdHFhU2ZnUEJoaWlLZmJlQWZlTk43enE4aXhNLUl2WHZsRlBGU1dnZUFfWFNoU1ZSUWx3QW96UjZsaWlyeE56LUZ3TjZ4R1RqN09MQzE3NmlSS1RBX0RzZW9GOTVoR1VoUGNjS1BUbUVTNzhhNXQyREE?oc=5" target="_blank"&gt;Botox maker Allergan close to $66bn tie-up with Actavis&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Guardian&lt;/font&gt;</description><source url="https://www.theguardian.com">The Guardian</source></item><item><title>Watson Pharma acquires Actavis - Projects Today</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTFBjN1hSNFdaU1NwMnpXcFE3YVpGcGpEaEdMRzY0bWM4TVBvc096UWdQQ3NTb3NvZ2NTQnRUMVBhT0FNWDBESTNkS0x0Nkk2d2FDd2RPWG9DdGo1TnROVGhpLVQyQ3hSbEptRC1tRGpMZEtZZw?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTFBjN1hSNFdaU1NwMnpXcFE3YVpGcGpEaEdMRzY0bWM4TVBvc096UWdQQ3NTb3NvZ2NTQnRUMVBhT0FNWDBESTNkS0x0Nkk2d2FDd2RPWG9DdGo1TnROVGhpLVQyQ3hSbEptRC1tRGpMZEtZZw</guid><pubDate>Fri, 02 Nov 2012 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTFBjN1hSNFdaU1NwMnpXcFE3YVpGcGpEaEdMRzY0bWM4TVBvc096UWdQQ3NTb3NvZ2NTQnRUMVBhT0FNWDBESTNkS0x0Nkk2d2FDd2RPWG9DdGo1TnROVGhpLVQyQ3hSbEptRC1tRGpMZEtZZw?oc=5" target="_blank"&gt;Watson Pharma acquires Actavis&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Projects Today&lt;/font&gt;</description><source url="https://www.projectstoday.ai">Projects Today</source></item><item><title>Actavis changes its name to Allergan - Pharmafile</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE84a1JqNFM2TTA4M2lfWXRqZ0xCYUtuTGNmY0VDcXBkZVlFWDNuc1Bob2Vna05OQXVYbnFvZTA2Q3NmSXNQN2trSlMta2p6SjM2UGtTY0RkRmI4cEZfYnFrQ0VuRTI3Sm9QRjNJeFQ3UQ?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE84a1JqNFM2TTA4M2lfWXRqZ0xCYUtuTGNmY0VDcXBkZVlFWDNuc1Bob2Vna05OQXVYbnFvZTA2Q3NmSXNQN2trSlMta2p6SjM2UGtTY0RkRmI4cEZfYnFrQ0VuRTI3Sm9QRjNJeFQ3UQ</guid><pubDate>Tue, 16 Jun 2015 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE84a1JqNFM2TTA4M2lfWXRqZ0xCYUtuTGNmY0VDcXBkZVlFWDNuc1Bob2Vna05OQXVYbnFvZTA2Q3NmSXNQN2trSlMta2p6SjM2UGtTY0RkRmI4cEZfYnFrQ0VuRTI3Sm9QRjNJeFQ3UQ?oc=5" target="_blank"&gt;Actavis changes its name to Allergan&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Pharmafile&lt;/font&gt;</description><source url="https://pharmafile.com">Pharmafile</source></item><item><title>Actavis agrees to acquire Allergan in $66bn mega deal - Financier Worldwide</title><link>https://news.google.com/rss/articles/CBMikAFBVV95cUxOZktLQjVVTmtXdzhiNFduZmJPQVlZUlJvamZ0dTY4LVB3UVhfSDdwQjNQdWJnODNycnlmRDZ0QVhOVm9wRjB5SG9aZkJWbjIyemZzcVotZ2s1M0VTUE5HQm1EOTBDTzMwaVBvQ2N0RHVhMmRLSDRBc0NJRnJMcmhXQWpiVjByNi1sR0w3a25xaVI?oc=5</link><guid isPermaLink="false">CBMikAFBVV95cUxOZktLQjVVTmtXdzhiNFduZmJPQVlZUlJvamZ0dTY4LVB3UVhfSDdwQjNQdWJnODNycnlmRDZ0QVhOVm9wRjB5SG9aZkJWbjIyemZzcVotZ2s1M0VTUE5HQm1EOTBDTzMwaVBvQ2N0RHVhMmRLSDRBc0NJRnJMcmhXQWpiVjByNi1sR0w3a25xaVI</guid><pubDate>Tue, 15 Nov 2016 12:32:21 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOZktLQjVVTmtXdzhiNFduZmJPQVlZUlJvamZ0dTY4LVB3UVhfSDdwQjNQdWJnODNycnlmRDZ0QVhOVm9wRjB5SG9aZkJWbjIyemZzcVotZ2s1M0VTUE5HQm1EOTBDTzMwaVBvQ2N0RHVhMmRLSDRBc0NJRnJMcmhXQWpiVjByNi1sR0w3a25xaVI?oc=5" target="_blank"&gt;Actavis agrees to acquire Allergan in $66bn mega deal&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Financier Worldwide&lt;/font&gt;</description><source url="https://www.financierworldwide.com">Financier Worldwide</source></item><item><title>Actavis to axe 200 jobs - Pharmafile</title><link>https://news.google.com/rss/articles/CBMiXkFVX3lxTE02bUpYdlZHWlZNSmV4ZVFTQVFWQ3czRjk0OEd4YXFxbGQtemo1V0haMHhqdklUbDV1MmQwdWc5bFdkTmlDVXYxNm5Ic3otcHFkbTcwZzU3bTNqSHc4V1E?oc=5</link><guid isPermaLink="false">CBMiXkFVX3lxTE02bUpYdlZHWlZNSmV4ZVFTQVFWQ3czRjk0OEd4YXFxbGQtemo1V0haMHhqdklUbDV1MmQwdWc5bFdkTmlDVXYxNm5Ic3otcHFkbTcwZzU3bTNqSHc4V1E</guid><pubDate>Thu, 04 Dec 2014 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE02bUpYdlZHWlZNSmV4ZVFTQVFWQ3czRjk0OEd4YXFxbGQtemo1V0haMHhqdklUbDV1MmQwdWc5bFdkTmlDVXYxNm5Ic3otcHFkbTcwZzU3bTNqSHc4V1E?oc=5" target="_blank"&gt;Actavis to axe 200 jobs&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Pharmafile&lt;/font&gt;</description><source url="https://pharmafile.com">Pharmafile</source></item><item><title>Tris blocks Actavis’ ADHD generic - Life Sciences Intellectual Property Review</title><link>https://news.google.com/rss/articles/CBMiiwFBVV95cUxPZWV2MlJqTV9jdTJweUNVUGMxLTlueWc0cThQTjMyenQ5elBkbDhUMVJqamVtWWJQNlJsdFJKUlQ0RkwwUFN2NFE0SWM3S25rOC1ybTBfYnh0QWF0NnRNZ0RKaGthNlo5eGNmczRLVEY5ZVJpcmpPTGRyUDFBSVdfSFRmMEtWQl9ibWNv?oc=5</link><guid isPermaLink="false">CBMiiwFBVV95cUxPZWV2MlJqTV9jdTJweUNVUGMxLTlueWc0cThQTjMyenQ5elBkbDhUMVJqamVtWWJQNlJsdFJKUlQ0RkwwUFN2NFE0SWM3S25rOC1ybTBfYnh0QWF0NnRNZ0RKaGthNlo5eGNmczRLVEY5ZVJpcmpPTGRyUDFBSVdfSFRmMEtWQl9ibWNv</guid><pubDate>Thu, 10 Dec 2020 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPZWV2MlJqTV9jdTJweUNVUGMxLTlueWc0cThQTjMyenQ5elBkbDhUMVJqamVtWWJQNlJsdFJKUlQ0RkwwUFN2NFE0SWM3S25rOC1ybTBfYnh0QWF0NnRNZ0RKaGthNlo5eGNmczRLVEY5ZVJpcmpPTGRyUDFBSVdfSFRmMEtWQl9ibWNv?oc=5" target="_blank"&gt;Tris blocks Actavis’ ADHD generic&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Life Sciences Intellectual Property Review&lt;/font&gt;</description><source url="https://www.lifesciencesipreview.com">Life Sciences Intellectual Property Review</source></item><item><title>LILETTA™ Now Available - MultiVu</title><link>https://news.google.com/rss/articles/CBMiggFBVV95cUxNQks5QlBYc3dxOUQyOVEwUjV1RnlLWFJ6cDFvQXVsaERyMGd3UzctbHk0QVF4dWVtM2ZUdUVqbmtHQmRNSUJwWHBuajVEQkxWa2txQmJwXzlXbXQ0c1ZmRFVWUmJzYk5leks2QmRlLXBoUm5kSXdISlVsUTFTVU1MTU9n?oc=5</link><guid isPermaLink="false">CBMiggFBVV95cUxNQks5QlBYc3dxOUQyOVEwUjV1RnlLWFJ6cDFvQXVsaERyMGd3UzctbHk0QVF4dWVtM2ZUdUVqbmtHQmRNSUJwWHBuajVEQkxWa2txQmJwXzlXbXQ0c1ZmRFVWUmJzYk5leks2QmRlLXBoUm5kSXdISlVsUTFTVU1MTU9n</guid><pubDate>Mon, 13 Apr 2015 20:34:31 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxNQks5QlBYc3dxOUQyOVEwUjV1RnlLWFJ6cDFvQXVsaERyMGd3UzctbHk0QVF4dWVtM2ZUdUVqbmtHQmRNSUJwWHBuajVEQkxWa2txQmJwXzlXbXQ0c1ZmRFVWUmJzYk5leks2QmRlLXBoUm5kSXdISlVsUTFTVU1MTU9n?oc=5" target="_blank"&gt;LILETTA™ Now Available&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MultiVu&lt;/font&gt;</description><source url="http://www.multivu.com">MultiVu</source></item><item><title>UK pharma firms accused of illegal deals to hike price of life-saving drug - The Guardian</title><link>https://news.google.com/rss/articles/CBMiwAFBVV95cUxNT0NkbV9OWXFUTzV6VjBVaUROSU44RDdhQ2NDSUh0dEtVeENzdHNnVFliTDY0c0x4d2dFZEFxTWY4bzZaZWdWTnRzUW1fUi1vdHdOOGtTa3ZGWlBjaFVHUzdpZVpPcHNidGstT1BHZVpKNXpGbHBoUVFqZTVlTlo0SU5qc3hrTVFja19xNGhRZVRNSzRHcmJqdHUwdzdlbzdHR0VhM2FMR1VlaEtTclNVa1pheFBwN1FFYjlvU2lqYko?oc=5</link><guid isPermaLink="false">CBMiwAFBVV95cUxNT0NkbV9OWXFUTzV6VjBVaUROSU44RDdhQ2NDSUh0dEtVeENzdHNnVFliTDY0c0x4d2dFZEFxTWY4bzZaZWdWTnRzUW1fUi1vdHdOOGtTa3ZGWlBjaFVHUzdpZVpPcHNidGstT1BHZVpKNXpGbHBoUVFqZTVlTlo0SU5qc3hrTVFja19xNGhRZVRNSzRHcmJqdHUwdzdlbzdHR0VhM2FMR1VlaEtTclNVa1pheFBwN1FFYjlvU2lqYko</guid><pubDate>Fri, 03 Mar 2017 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNT0NkbV9OWXFUTzV6VjBVaUROSU44RDdhQ2NDSUh0dEtVeENzdHNnVFliTDY0c0x4d2dFZEFxTWY4bzZaZWdWTnRzUW1fUi1vdHdOOGtTa3ZGWlBjaFVHUzdpZVpPcHNidGstT1BHZVpKNXpGbHBoUVFqZTVlTlo0SU5qc3hrTVFja19xNGhRZVRNSzRHcmJqdHUwdzdlbzdHR0VhM2FMR1VlaEtTclNVa1pheFBwN1FFYjlvU2lqYko?oc=5" target="_blank"&gt;UK pharma firms accused of illegal deals to hike price of life-saving drug&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Guardian&lt;/font&gt;</description><source url="https://www.theguardian.com">The Guardian</source></item><item><title>FDA balks on generic Concerta as Mallinckrodt, Actavis meds gobble up market - Fierce Pharma</title><link>https://news.google.com/rss/articles/CBMitgFBVV95cUxPdG8tdng2Qzd0NnEzbU56RnpiX0pkbHY3cnp3VjFkR2tMYnNNWkdCU3pyS2Jtb0MzN3RKS09DZTA1bTBkV00zZGl0TU04T25QbzV2Mml0VVo0Z19zRmc5V3dGeXMzWlRfUXlhLTRnUlRaZ0ppOWFvX1hLa05EM0xYM0xpSEZ6R1NJcWt3akgwVml4M09aN3prOUVDb25RbVZnbkVGOUtkdmliNXd2N2o4QXQ4VUlCZw?oc=5</link><guid isPermaLink="false">CBMitgFBVV95cUxPdG8tdng2Qzd0NnEzbU56RnpiX0pkbHY3cnp3VjFkR2tMYnNNWkdCU3pyS2Jtb0MzN3RKS09DZTA1bTBkV00zZGl0TU04T25QbzV2Mml0VVo0Z19zRmc5V3dGeXMzWlRfUXlhLTRnUlRaZ0ppOWFvX1hLa05EM0xYM0xpSEZ6R1NJcWt3akgwVml4M09aN3prOUVDb25RbVZnbkVGOUtkdmliNXd2N2o4QXQ4VUlCZw</guid><pubDate>Wed, 17 Jun 2015 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPdG8tdng2Qzd0NnEzbU56RnpiX0pkbHY3cnp3VjFkR2tMYnNNWkdCU3pyS2Jtb0MzN3RKS09DZTA1bTBkV00zZGl0TU04T25QbzV2Mml0VVo0Z19zRmc5V3dGeXMzWlRfUXlhLTRnUlRaZ0ppOWFvX1hLa05EM0xYM0xpSEZ6R1NJcWt3akgwVml4M09aN3prOUVDb25RbVZnbkVGOUtkdmliNXd2N2o4QXQ4VUlCZw?oc=5" target="_blank"&gt;FDA balks on generic Concerta as Mallinckrodt, Actavis meds gobble up market&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Fierce Pharma&lt;/font&gt;</description><source url="https://www.fiercepharma.com">Fierce Pharma</source></item><item><title>Actavis Reintroduces Oxycodone In The US - Pharmaceutical Online</title><link>https://news.google.com/rss/articles/CBMijwFBVV95cUxPYXpvVnowU0M3M2tHWW8tRjhiQzFTa1doZzI3VXBDUnV4cjV3ajlIQlJ4bkFiaG9RODdSTkxiTVVSNHNVejVsVHRRVjNSa3NBV0JKbWVDNloxdzRLcHd3NkF1b0w2QWlQYkNWRE5HUF9zV2dYYlZ1ZWdteThtalFTTHVIeDF2VXpYNjlBNU43OA?oc=5</link><guid isPermaLink="false">CBMijwFBVV95cUxPYXpvVnowU0M3M2tHWW8tRjhiQzFTa1doZzI3VXBDUnV4cjV3ajlIQlJ4bkFiaG9RODdSTkxiTVVSNHNVejVsVHRRVjNSa3NBV0JKbWVDNloxdzRLcHd3NkF1b0w2QWlQYkNWRE5HUF9zV2dYYlZ1ZWdteThtalFTTHVIeDF2VXpYNjlBNU43OA</guid><pubDate>Tue, 21 Apr 2009 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxPYXpvVnowU0M3M2tHWW8tRjhiQzFTa1doZzI3VXBDUnV4cjV3ajlIQlJ4bkFiaG9RODdSTkxiTVVSNHNVejVsVHRRVjNSa3NBV0JKbWVDNloxdzRLcHd3NkF1b0w2QWlQYkNWRE5HUF9zV2dYYlZ1ZWdteThtalFTTHVIeDF2VXpYNjlBNU43OA?oc=5" target="_blank"&gt;Actavis Reintroduces Oxycodone In The US&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Pharmaceutical Online&lt;/font&gt;</description><source url="https://www.pharmaceuticalonline.com">Pharmaceutical Online</source></item><item><title>Icelandic Pharmaceutical Company Actavis Sold - Iceland Review</title><link>https://news.google.com/rss/articles/CBMiiAFBVV95cUxOMEFSV2FRTlJmMmlaeWk5bjE1elJpY2VDMGllc2hoUUd2b1BkSzM2bmZFenNIQVotd2JuSmZXM1NmSFU5OGE0V0E3UFlzMGNnRmZKQzZXNGtZVFdKN3h3M3ZNaFVaSUVpTnJ2enVHbFVXQmtzSWhkSUp4bWJFNEhxZTFkVlFnblZK?oc=5</link><guid isPermaLink="false">CBMiiAFBVV95cUxOMEFSV2FRTlJmMmlaeWk5bjE1elJpY2VDMGllc2hoUUd2b1BkSzM2bmZFenNIQVotd2JuSmZXM1NmSFU5OGE0V0E3UFlzMGNnRmZKQzZXNGtZVFdKN3h3M3ZNaFVaSUVpTnJ2enVHbFVXQmtzSWhkSUp4bWJFNEhxZTFkVlFnblZK</guid><pubDate>Thu, 26 Apr 2012 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxOMEFSV2FRTlJmMmlaeWk5bjE1elJpY2VDMGllc2hoUUd2b1BkSzM2bmZFenNIQVotd2JuSmZXM1NmSFU5OGE0V0E3UFlzMGNnRmZKQzZXNGtZVFdKN3h3M3ZNaFVaSUVpTnJ2enVHbFVXQmtzSWhkSUp4bWJFNEhxZTFkVlFnblZK?oc=5" target="_blank"&gt;Icelandic Pharmaceutical Company Actavis Sold&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Iceland Review&lt;/font&gt;</description><source url="https://www.icelandreview.com">Iceland Review</source></item><item><title>Actavis sells businesses in western Europe to Aurobindo - The Irish Times</title><link>https://news.google.com/rss/articles/CBMitgFBVV95cUxPVlhucUI5bUg5cnRiSG11aEhQQk5IYUhJLUxobDNnd1ZjbGFvN1FvTUtYRnk5STgyT2szOV9EQlNhRmVkTDRObUlYcF9OZHJQc3lGZDNJYzN3SWhUYkNkSllteVlCUUtiQXFTVDFzejBacFA0dlNrb2E1blNWMVNKWlltSzlubnA1OXBDZjhNcU9wbXF5MUZxdzM2WGVrbG1rTjRhXzRXazRzLUZLalA3VlU5V1NvZw?oc=5</link><guid isPermaLink="false">CBMitgFBVV95cUxPVlhucUI5bUg5cnRiSG11aEhQQk5IYUhJLUxobDNnd1ZjbGFvN1FvTUtYRnk5STgyT2szOV9EQlNhRmVkTDRObUlYcF9OZHJQc3lGZDNJYzN3SWhUYkNkSllteVlCUUtiQXFTVDFzejBacFA0dlNrb2E1blNWMVNKWlltSzlubnA1OXBDZjhNcU9wbXF5MUZxdzM2WGVrbG1rTjRhXzRXazRzLUZLalA3VlU5V1NvZw</guid><pubDate>Sun, 19 Jan 2014 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPVlhucUI5bUg5cnRiSG11aEhQQk5IYUhJLUxobDNnd1ZjbGFvN1FvTUtYRnk5STgyT2szOV9EQlNhRmVkTDRObUlYcF9OZHJQc3lGZDNJYzN3SWhUYkNkSllteVlCUUtiQXFTVDFzejBacFA0dlNrb2E1blNWMVNKWlltSzlubnA1OXBDZjhNcU9wbXF5MUZxdzM2WGVrbG1rTjRhXzRXazRzLUZLalA3VlU5V1NvZw?oc=5" target="_blank"&gt;Actavis sells businesses in western Europe to Aurobindo&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Irish Times&lt;/font&gt;</description><source url="https://www.irishtimes.com">The Irish Times</source></item><item><title>Intas buys Actavis assets in UK, Ireland for Rs 5,100cr - The Times of India</title><link>https://news.google.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?oc=5</link><guid isPermaLink="false">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</guid><pubDate>Thu, 06 Oct 2016 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.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?oc=5" target="_blank"&gt;Intas buys Actavis assets in UK, Ireland for Rs 5,100cr&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Times of India&lt;/font&gt;</description><source url="https://timesofindia.indiatimes.com">The Times of India</source></item><item><title>Ireland’s Actavis buys Warner Chilcott for $8.5B - News is My Business</title><link>https://news.google.com/rss/articles/CBMiggFBVV95cUxNQU5IczdyWTZjUEpoSXdpLXFkMTdxT0RWYUNoai1nSGJQbWp3am81YjB6eWhITlRabXpYcUhINUtRWlAxMUEtMm9ueE5CQmwzRjBzWGFOX3NSdGRmNW9pQ0hZN3ZicDlYd01fYXFHRVpsdHNuZVVnMVV6cUdqTGc4NnFn?oc=5</link><guid isPermaLink="false">CBMiggFBVV95cUxNQU5IczdyWTZjUEpoSXdpLXFkMTdxT0RWYUNoai1nSGJQbWp3am81YjB6eWhITlRabXpYcUhINUtRWlAxMUEtMm9ueE5CQmwzRjBzWGFOX3NSdGRmNW9pQ0hZN3ZicDlYd01fYXFHRVpsdHNuZVVnMVV6cUdqTGc4NnFn</guid><pubDate>Wed, 02 Oct 2013 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxNQU5IczdyWTZjUEpoSXdpLXFkMTdxT0RWYUNoai1nSGJQbWp3am81YjB6eWhITlRabXpYcUhINUtRWlAxMUEtMm9ueE5CQmwzRjBzWGFOX3NSdGRmNW9pQ0hZN3ZicDlYd01fYXFHRVpsdHNuZVVnMVV6cUdqTGc4NnFn?oc=5" target="_blank"&gt;Ireland’s Actavis buys Warner Chilcott for $8.5B&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;News is My Business&lt;/font&gt;</description><source url="https://newsismybusiness.com">News is My Business</source></item><item><title>Actavis claims top UK generics spot with Auden Mckenzie buy - PMLiVE</title><link>https://news.google.com/rss/articles/CBMinwFBVV95cUxQRU5lcFdmOVlzZGNBOFpLcWFVZUl0emhIS0dtcm1xSmhkcmszLXlOQWMtTnpqenJrLUVFVF95a2M4TG96NjVXVEZjZW5pWWpHc1FRVUtNRm9udE5TYy11djRYMzdTMnpKeHJyc1B2VjRzUjJtaDVGRmdfcTNRYVVzMjNLN1owSnVROUFlYlFadW9RTnhkM2lPeFFrN0h4dms?oc=5</link><guid isPermaLink="false">CBMinwFBVV95cUxQRU5lcFdmOVlzZGNBOFpLcWFVZUl0emhIS0dtcm1xSmhkcmszLXlOQWMtTnpqenJrLUVFVF95a2M4TG96NjVXVEZjZW5pWWpHc1FRVUtNRm9udE5TYy11djRYMzdTMnpKeHJyc1B2VjRzUjJtaDVGRmdfcTNRYVVzMjNLN1owSnVROUFlYlFadW9RTnhkM2lPeFFrN0h4dms</guid><pubDate>Tue, 27 Jan 2015 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQRU5lcFdmOVlzZGNBOFpLcWFVZUl0emhIS0dtcm1xSmhkcmszLXlOQWMtTnpqenJrLUVFVF95a2M4TG96NjVXVEZjZW5pWWpHc1FRVUtNRm9udE5TYy11djRYMzdTMnpKeHJyc1B2VjRzUjJtaDVGRmdfcTNRYVVzMjNLN1owSnVROUFlYlFadW9RTnhkM2lPeFFrN0h4dms?oc=5" target="_blank"&gt;Actavis claims top UK generics spot with Auden Mckenzie buy&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PMLiVE&lt;/font&gt;</description><source url="https://pmlive.com">PMLiVE</source></item><item><title>Intas acquires generics business of Actavis in UK, Ireland - Express Pharma</title><link>https://news.google.com/rss/articles/CBMipgFBVV95cUxObHRnVS1PclFrTWF1QzdubHJ6cWMxY0pGUUhVQkdLRk9ZTUhEU2tkTkpzaFIxdEhBVHMwam5tbzVPaDBWa1FPTGJ3bUhCVmdxRDdLSHBjQXFrOTFtRjRSeTAyUG5KWUgxb3RpclVUWDFlVnJTdktCTXVOWlNDQ3BhNTR2YmJYd2xZTkgtbDhzU0E1T193bkVxTUVFS0c4R0FpWm00SnZ30gGrAUFVX3lxTE5TdGk1NzFDcWpBcTI3RlZPXzVMb2w5aFo5bUEtcFlETmhpRGNzLUtTTnJIaGJIWEJ2UzcxUnNiX0lPMEJpZ2JTbVY3YWFJMzh0OG55WmtOb3V5VGtiZkhiM0Z3S25WbXduTWMwQmJsOVc3Z0dhSVNGUXgtMTZPNmstMWMwaGRmdGV0QlI0LVVPcENtT0gyTFZZWF9iajJDLUxyYWJUMjZ1YnBFMA?oc=5</link><guid isPermaLink="false">CBMipgFBVV95cUxObHRnVS1PclFrTWF1QzdubHJ6cWMxY0pGUUhVQkdLRk9ZTUhEU2tkTkpzaFIxdEhBVHMwam5tbzVPaDBWa1FPTGJ3bUhCVmdxRDdLSHBjQXFrOTFtRjRSeTAyUG5KWUgxb3RpclVUWDFlVnJTdktCTXVOWlNDQ3BhNTR2YmJYd2xZTkgtbDhzU0E1T193bkVxTUVFS0c4R0FpWm00SnZ30gGrAUFVX3lxTE5TdGk1NzFDcWpBcTI3RlZPXzVMb2w5aFo5bUEtcFlETmhpRGNzLUtTTnJIaGJIWEJ2UzcxUnNiX0lPMEJpZ2JTbVY3YWFJMzh0OG55WmtOb3V5VGtiZkhiM0Z3S25WbXduTWMwQmJsOVc3Z0dhSVNGUXgtMTZPNmstMWMwaGRmdGV0QlI0LVVPcENtT0gyTFZZWF9iajJDLUxyYWJUMjZ1YnBFMA</guid><pubDate>Fri, 12 Jan 2018 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxObHRnVS1PclFrTWF1QzdubHJ6cWMxY0pGUUhVQkdLRk9ZTUhEU2tkTkpzaFIxdEhBVHMwam5tbzVPaDBWa1FPTGJ3bUhCVmdxRDdLSHBjQXFrOTFtRjRSeTAyUG5KWUgxb3RpclVUWDFlVnJTdktCTXVOWlNDQ3BhNTR2YmJYd2xZTkgtbDhzU0E1T193bkVxTUVFS0c4R0FpWm00SnZ30gGrAUFVX3lxTE5TdGk1NzFDcWpBcTI3RlZPXzVMb2w5aFo5bUEtcFlETmhpRGNzLUtTTnJIaGJIWEJ2UzcxUnNiX0lPMEJpZ2JTbVY3YWFJMzh0OG55WmtOb3V5VGtiZkhiM0Z3S25WbXduTWMwQmJsOVc3Z0dhSVNGUXgtMTZPNmstMWMwaGRmdGV0QlI0LVVPcENtT0gyTFZZWF9iajJDLUxyYWJUMjZ1YnBFMA?oc=5" target="_blank"&gt;Intas acquires generics business of Actavis in UK, Ireland&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Express Pharma&lt;/font&gt;</description><source url="https://www.expresspharma.in">Express Pharma</source></item><item><title>Aurobindo completes acquisition of select Actavis operations - The Economic Times</title><link>https://news.google.com/rss/articles/CBMi7gFBVV95cUxOMXE3SGNnbkx3OGFVVGxuR05QbENOV3FXeEJFVW5vUGhRUC1nZk5rYTNhakpCY3d1ckZ0c2wtQ01EelNidHBxVzBacjdGVHREMXdLODY0LTNXWXIxX0Y4MmVxMEhTZXR2Nkp2OGFOcnMwNE9jNllVOXJBUDJ4c1FUell2alc3MkVyMFVLeGhSV1hEYnFHTVlibzdxTmp0RGxOV0xncUxBMnBRR0o2RWVkZldmQ0tKWEszWk9LQ3NEaXA2UmZRM1FzZ2FEMDlGc2V1RC04aUVKRURUSWhUUTFNMFYtRXBvdTBQTGZvdWp3?oc=5</link><guid isPermaLink="false">CBMi7gFBVV95cUxOMXE3SGNnbkx3OGFVVGxuR05QbENOV3FXeEJFVW5vUGhRUC1nZk5rYTNhakpCY3d1ckZ0c2wtQ01EelNidHBxVzBacjdGVHREMXdLODY0LTNXWXIxX0Y4MmVxMEhTZXR2Nkp2OGFOcnMwNE9jNllVOXJBUDJ4c1FUell2alc3MkVyMFVLeGhSV1hEYnFHTVlibzdxTmp0RGxOV0xncUxBMnBRR0o2RWVkZldmQ0tKWEszWk9LQ3NEaXA2UmZRM1FzZ2FEMDlGc2V1RC04aUVKRURUSWhUUTFNMFYtRXBvdTBQTGZvdWp3</guid><pubDate>Tue, 01 Apr 2014 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxOMXE3SGNnbkx3OGFVVGxuR05QbENOV3FXeEJFVW5vUGhRUC1nZk5rYTNhakpCY3d1ckZ0c2wtQ01EelNidHBxVzBacjdGVHREMXdLODY0LTNXWXIxX0Y4MmVxMEhTZXR2Nkp2OGFOcnMwNE9jNllVOXJBUDJ4c1FUell2alc3MkVyMFVLeGhSV1hEYnFHTVlibzdxTmp0RGxOV0xncUxBMnBRR0o2RWVkZldmQ0tKWEszWk9LQ3NEaXA2UmZRM1FzZ2FEMDlGc2V1RC04aUVKRURUSWhUUTFNMFYtRXBvdTBQTGZvdWp3?oc=5" target="_blank"&gt;Aurobindo completes acquisition of select Actavis operations&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Economic Times&lt;/font&gt;</description><source url="https://m.economictimes.com">The Economic Times</source></item><item><title>Vivimed acquires Actavis Pharma's facility for Rs 122 crore - The Economic Times</title><link>https://news.google.com/rss/articles/CBMi6wFBVV95cUxNVXFHX1ZjMGxnajBIMGxEMHd6Uy1LSG5VOGdDMllYXzhzZzlCX1VCaFRvVzFHM014QzZQcndjdi1UbldNRTZWeUR6QkFtWmRIVEVHR2Fqc3d2WUV1LUF4OUJqOFo5aHZOSFBBUjMySl9jVVhQQUQ3ejdyWGJQbGZVT2JJUEJPYXU4d2xaU2pxUzJkaDFkYTVhWW5OeWZYbkdjbkl3Tlg3dzliT3dzYVFENXRiZUpXOC1hVHZhRTlub09uNjZlVW1xQUh6Y05tdnpaUWM1cy1TcVU1STdWenpqLUlCaUFxUlJWdlZj?oc=5</link><guid isPermaLink="false">CBMi6wFBVV95cUxNVXFHX1ZjMGxnajBIMGxEMHd6Uy1LSG5VOGdDMllYXzhzZzlCX1VCaFRvVzFHM014QzZQcndjdi1UbldNRTZWeUR6QkFtWmRIVEVHR2Fqc3d2WUV1LUF4OUJqOFo5aHZOSFBBUjMySl9jVVhQQUQ3ejdyWGJQbGZVT2JJUEJPYXU4d2xaU2pxUzJkaDFkYTVhWW5OeWZYbkdjbkl3Tlg3dzliT3dzYVFENXRiZUpXOC1hVHZhRTlub09uNjZlVW1xQUh6Y05tdnpaUWM1cy1TcVU1STdWenpqLUlCaUFxUlJWdlZj</guid><pubDate>Thu, 01 Aug 2013 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxNVXFHX1ZjMGxnajBIMGxEMHd6Uy1LSG5VOGdDMllYXzhzZzlCX1VCaFRvVzFHM014QzZQcndjdi1UbldNRTZWeUR6QkFtWmRIVEVHR2Fqc3d2WUV1LUF4OUJqOFo5aHZOSFBBUjMySl9jVVhQQUQ3ejdyWGJQbGZVT2JJUEJPYXU4d2xaU2pxUzJkaDFkYTVhWW5OeWZYbkdjbkl3Tlg3dzliT3dzYVFENXRiZUpXOC1hVHZhRTlub09uNjZlVW1xQUh6Y05tdnpaUWM1cy1TcVU1STdWenpqLUlCaUFxUlJWdlZj?oc=5" target="_blank"&gt;Vivimed acquires Actavis Pharma's facility for Rs 122 crore&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;The Economic Times&lt;/font&gt;</description><source url="https://m.economictimes.com">The Economic Times</source></item><item><title>The business wrap: Intas Pharma to buy Actavis businesses from Teva, and six other top stories - Scroll.in</title><link>https://news.google.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?oc=5</link><guid isPermaLink="false">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</guid><pubDate>Thu, 06 Oct 2016 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.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?oc=5" target="_blank"&gt;The business wrap: Intas Pharma to buy Actavis businesses from Teva, and six other top stories&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Scroll.in&lt;/font&gt;</description><source url="https://scroll.in">Scroll.in</source></item><item><title>Frontier Pharma and Baystone Group acquire Serbian pharmaceutical company Zdravlje - Serbian Monitor</title><link>https://news.google.com/rss/articles/CBMiuAFBVV95cUxQVlF4a3ZURTRhNmd5N1dIMmExcVdISkJsX2ZWVVVWV0RSRy1jdGVJS2dBZUxoZk0wcFJFOENvUmhUdExwcmlqeG9TbUFwYUNVVXF5ZDdiSzFmOWMxaDZuTkZtTld3RmVzZG9DVDJGTVdCSjJDdnJXXzlocHZVUHFiOWk4NS04UEV1ZlFyUG5TWUdrT0tVMGJRU3JJUkxfYUMyWWVQMG04WGl0dkhiV2FzU183ckRhZno1?oc=5</link><guid isPermaLink="false">CBMiuAFBVV95cUxQVlF4a3ZURTRhNmd5N1dIMmExcVdISkJsX2ZWVVVWV0RSRy1jdGVJS2dBZUxoZk0wcFJFOENvUmhUdExwcmlqeG9TbUFwYUNVVXF5ZDdiSzFmOWMxaDZuTkZtTld3RmVzZG9DVDJGTVdCSjJDdnJXXzlocHZVUHFiOWk4NS04UEV1ZlFyUG5TWUdrT0tVMGJRU3JJUkxfYUMyWWVQMG04WGl0dkhiV2FzU183ckRhZno1</guid><pubDate>Tue, 12 Jan 2021 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQVlF4a3ZURTRhNmd5N1dIMmExcVdISkJsX2ZWVVVWV0RSRy1jdGVJS2dBZUxoZk0wcFJFOENvUmhUdExwcmlqeG9TbUFwYUNVVXF5ZDdiSzFmOWMxaDZuTkZtTld3RmVzZG9DVDJGTVdCSjJDdnJXXzlocHZVUHFiOWk4NS04UEV1ZlFyUG5TWUdrT0tVMGJRU3JJUkxfYUMyWWVQMG04WGl0dkhiV2FzU183ckRhZno1?oc=5" target="_blank"&gt;Frontier Pharma and Baystone Group acquire Serbian pharmaceutical company Zdravlje&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Serbian Monitor&lt;/font&gt;</description><source url="https://www.serbianmonitor.com">Serbian Monitor</source></item><item><title>Vivimed buys Actavis Pharma's unit for Rs 122 cr - Business Standard</title><link>https://news.google.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?oc=5</link><guid isPermaLink="false">CBMivAFBVV95cUxOdThTdVpsLUNYdGlHak5kWnhXbVNpZnVlRDNWUUMzNTBGZURPVGFiUmlnTXNrR3Vza3FwOVduYVJZSXBNV2d1N213TnNNLUY3b29fSUpUOHBXMUNFTXVzOHVzRDlKb1JKZ1VuZ2g2WXJVVFotbUh0ZElCUmNjRTBKQjY0V3BUSWNWQ1o3aWg4OVdKQ0RncDlad0pCTjZvTTZSU0NBdUhvSXg3VmlFUF9UWFJSWlVxVU50aE91StIBwgFBVV95cUxNN0IzV21LMW1jOG5VYmpNRVNtbTdaNUlLYlVsREFtMnN0NHVwU0dtVGt3YXU5NnlnYjA1aUUzYVE4ektpS1hyQ3JlRERTRDBxOXdGdmdnWThpZG50NVlQMDd5Tk1NbFlzWWhNd0oyS2VnNC1sUEYxMldnaXFaN21zRXpzbmU1enRMSlhPaFktbGN6V3oxQ3ZxcGl2ZmJ2UVFRTW9fNWN0Y2d2aVl2RFpmSXpzNE5GQTV5Qm9nYl9FUHJSZw</guid><pubDate>Thu, 01 Aug 2013 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.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?oc=5" target="_blank"&gt;Vivimed buys Actavis Pharma's unit for Rs 122 cr&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Business Standard&lt;/font&gt;</description><source url="https://www.business-standard.com">Business Standard</source></item><item><title>Watson Pharmaceuticals, Inc. is Now Actavis, Inc. (PICTURE) - Presseportal.ch</title><link>https://news.google.com/rss/articles/CBMiY0FVX3lxTE9EeW9QeVlqVXc3Qmtwc3pjbXMta1gzY09TVTJJdFk5UXJUS2hnNzd0MW1WTFVuN1BzRlpiMkpjZUNNck5Ib2ZlY3dUVmx6YmIzSzFkdm4tZEdYMHRoWjhBTHN3UQ?oc=5</link><guid isPermaLink="false">CBMiY0FVX3lxTE9EeW9QeVlqVXc3Qmtwc3pjbXMta1gzY09TVTJJdFk5UXJUS2hnNzd0MW1WTFVuN1BzRlpiMkpjZUNNck5Ib2ZlY3dUVmx6YmIzSzFkdm4tZEdYMHRoWjhBTHN3UQ</guid><pubDate>Wed, 30 Jan 2013 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTE9EeW9QeVlqVXc3Qmtwc3pjbXMta1gzY09TVTJJdFk5UXJUS2hnNzd0MW1WTFVuN1BzRlpiMkpjZUNNck5Ib2ZlY3dUVmx6YmIzSzFkdm4tZEdYMHRoWjhBTHN3UQ?oc=5" target="_blank"&gt;Watson Pharmaceuticals, Inc. is Now Actavis, Inc. (PICTURE)&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Presseportal.ch&lt;/font&gt;</description><source url="https://www.presseportal.ch">Presseportal.ch</source></item><item><title>Big Pharma’s tax-dodging history: Actavis ‘inversions’ won it billions in savings on American taxes - MaltaToday</title><link>https://news.google.com/rss/articles/CBMi6AFBVV95cUxPTVRkNks0VWtYRmVOb2sxeGRrdDVtbFp3dy1lQzh2UTduUjU3Zng4MWsyRE1ac3ZRS0tZaW00RzVNQV9JN0lQczNpazVLTjRYYi1QZTYtdWJ4MW9kYkU2akl0aDF3bnNNb0xXV2d4cGhUaEJCUW1xN0JDV1MzZGpFeUc1d0FKaG1ZdVJkV21fOWlsMHNNci05Ykt3QWlWcmZPdE1VNFNFTDUtVWsta1hJZ3NFMFlWT2VDRHpVLXhjMWJJTl9rWklPQW8tZURnQkNqdEtGZmp5SmZwcDdCYmgwdm5fc3EwVUt4?oc=5</link><guid isPermaLink="false">CBMi6AFBVV95cUxPTVRkNks0VWtYRmVOb2sxeGRrdDVtbFp3dy1lQzh2UTduUjU3Zng4MWsyRE1ac3ZRS0tZaW00RzVNQV9JN0lQczNpazVLTjRYYi1QZTYtdWJ4MW9kYkU2akl0aDF3bnNNb0xXV2d4cGhUaEJCUW1xN0JDV1MzZGpFeUc1d0FKaG1ZdVJkV21fOWlsMHNNci05Ykt3QWlWcmZPdE1VNFNFTDUtVWsta1hJZ3NFMFlWT2VDRHpVLXhjMWJJTl9rWklPQW8tZURnQkNqdEtGZmp5SmZwcDdCYmgwdm5fc3EwVUt4</guid><pubDate>Tue, 29 Nov 2016 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMi6AFBVV95cUxPTVRkNks0VWtYRmVOb2sxeGRrdDVtbFp3dy1lQzh2UTduUjU3Zng4MWsyRE1ac3ZRS0tZaW00RzVNQV9JN0lQczNpazVLTjRYYi1QZTYtdWJ4MW9kYkU2akl0aDF3bnNNb0xXV2d4cGhUaEJCUW1xN0JDV1MzZGpFeUc1d0FKaG1ZdVJkV21fOWlsMHNNci05Ykt3QWlWcmZPdE1VNFNFTDUtVWsta1hJZ3NFMFlWT2VDRHpVLXhjMWJJTl9rWklPQW8tZURnQkNqdEtGZmp5SmZwcDdCYmgwdm5fc3EwVUt4?oc=5" target="_blank"&gt;Big Pharma’s tax-dodging history: Actavis ‘inversions’ won it billions in savings on American taxes&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;MaltaToday&lt;/font&gt;</description><source url="https://www.maltatoday.com.mt">MaltaToday</source></item></channel></rss>